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Research relating to illicit use of prescription stimulants (IUPS) has, for the most
part, focused on describing behaviors of IUPS. However, there have been few attempts to
measure IUPS in a consistent manner or determine how to best predict IUPS in an
effective and concise manner. Data from Mississippi State University undergraduates (N
= 703) were analyzed to create two short-form measures to predict lifetime IUPS. The
data-driven short-form consisted of 15 items and 5 factors, and accurately classified
74.8% of participants as users versus non-users. The hand-picked short-form consisted of
8 items and 5 factors, and accurately classified 84.6% of participants as users versus nonusers. Results of this study can begin to provide information and possible tactics for
briefly and quickly measuring risk for IUPS, particularly in applied settings, like
university health centers or academic admissions. Future directions for research include
testing these created short-form measures with longitudinal data collection, validating the
measures on different populations, and determining if these measures can accurately
predict specific behaviors related to IUPS (e.g., diversion, IUPS within certain time
frames).
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INTRODUCTION
Illicit Use
Illicit use of prescription stimulants (IUPS) is a behavior that is frequent on
college campuses, comes with a number of risks, and has been measured in a variety of
ways. IUPS is typically conceptualized as any kind of misuse of prescription stimulant
medications, which include medications typically used to treat symptoms of AttentionDeficit/Hyperactivity Disorder (ADHD). These medications include Adderall, Ritalin,
and Strattera, among other brands and medication formulations (National Institute on
Drug Abuse [NIDA], 2014). Although prescription stimulant medication is prescribed as
a treatment for ADHD and other disorders, including narcolepsy, it has the potential for
abuse and use for nonmedical purposes. There are many risks related to IUPS, including
negative health outcomes, legal consequences, and possible academic and social
implications.
IUPS has been defined in different ways in the literature, including “illicit use,”
“nonmedical use,” and “recreational use” (Benotsch, Koester, Luckman, Martin, &
Cejka, 2011; Judson & Langdon, 2009; Sharp & Rosen, 2007). Some studies have
defined this behavior as either consuming someone else’s prescription stimulant
medication, misusing one’s own medication, or even combining with other substances,
although other studies have focused solely on consuming someone else’s medication.
1

Prevalence Rates
Studies of IUPS have focused mostly on college campuses, as this behavior seem to
be particularly common among college students, perhaps due to the academic
connotations of stimulant medications. There have been steady increases over the past
decade in reported IUPS by college students, with lifetime prevalence rates increasing
from 8.1% to 12.7% and past year prevalence rates increasing from 5.4% to 9.3%
(McCabe, West, Teter, & Boyd, 2014). In a 2013 review of the literature, Weyandt and
colleagues found that most studies in the literature were reporting prevalence rates
ranging from 5% to 35%. A meta-analysis conducted by Benson and colleagues (2015)
found an estimated prevalence of around 17%.
There are a number of reasons for the wide range of reported prevalence rates for
IUPS. Some reported prevalence rates result from studies of regional universities,
whereas other reported prevalence rates result from larger, nationwide samples, such as
Monitoring the Future (MTF; Johnston, O’Malley, Bachman, Schulenberg, & Miech,
2015). Prevalence rates may be affected by different regional samples, with colleges in
the northeast having higher prevalence rates (McCabe, Knight, Teter, & Wechsler, 2005).
Further, prevalence rates have been found to be higher at colleges with more competitive
admission standards (McCabe et al., 2005).
One major limitation in understanding the reported prevalence rates in the literature is
that prevalence rates will vary based on the time frame utilized. For example, prevalence
rates will likely be much higher if participants are asked if they have ever engaged in a
behavior. This lifetime prevalence may not be as useful in predicting current behaviors as
more recent use. Unfortunately, lifetime prevalence is more frequently measured in the
2

literature, with one review showing almost half of articles reporting lifetime prevalence
(Hachtel & Armstrong, 2016). Further, the weighted prevalence rates of more recent time
frames are much lower than lifetime prevalence rates, with one review showing a lifetime
prevalence rate of taking someone else’s prescription stimulant medication of 14.0%, a
past year prevalence rate of 7.0%, and a six-month prevalence rate of 4.1% (Hachtel &
Armstrong, 2016).
Correlates of IUPS
Many studies have attempted to determine certain factors that are highly related to
different kinds of IUPS. Certain demographic factors have been shown to be related to
IUPS, including race, gender, and collegiate class standing (McCabe, Teter, & Boyd,
2006). The most frequently cited demographic factor related to IUPS is Greek affiliation,
with members of Greek organizations being more likely to engage in multiple kinds of
IUPS (DeSantis, Anthony, & Cohen, 2013; Kilmer, Geisner, Gasser, & Lindgren, 2015;
McCabe et al., 2005; McCabe et al., 2006). Other factors shown to be related to IUPS are
previous licit and illicit drug use (Jardin, Looby, & Earleywine, 2011), disinhibition and
conduct problems (Van Eck, Markle, & Flory, 2012), knowledge about stimulant
medications and the possible side effects (Bavarian, Flay, Ketcham, & Smit, 2013), and
positive attitudes and expectancies regarding stimulant medication (Bavarian et al.,
2013). Energy drink consumption has also been shown to be related to IUPS (Arria et al.,
2010). Additionally, one’s perception of the harmfulness of engaging in IUPS has been
shown to be a risk factor for engaging in IUPS (Arria et al., 2008b). Although there are a
few studies that have looked at risk factors specifically for recent IUPS (i.e., use within
the past year or during college; Arria et al., 2008b; Arria et al., 2010; Bavarian et al.,
3

2013; McCabe et al., 2005; McCabe et al., 2006), many studies look only at correlates
related to lifetime IUPS. Further, although there are numerous factors that seem to be
related to IUPS, theoretical models and measures should attempt to take into account the
numerous examples of empirical evidence regarding different correlates of IUPS, as some
of these factors could play a causal role in IUPS.
Risks of IUPS
There are a number of negative risks and consequences related to IUPS,
particularly when such medications are taken in excess or too often. Prescription
stimulant medications have become increasingly prescribed and available since the
1990’s (Kaye & Darke, 2012). This means that there are increasing amounts of
prescription stimulant medications circulating, and thus, more available for illicit
consumption.
Health Risks
In 2013, the Substance Abuse and Mental Health Services Administration
(SAMHSA) published a report showing an increase in emergency department visits
related to illicit use of stimulants, including prescription stimulant medications. The
number of visits quadrupled between 2005 and 2011, suggesting a steady increase in
negative health consequences related to illicit use of different kinds of stimulants
(SAMHSA, 2013). Even with prescribed use of prescription stimulant medications, there
are a number of possible negative side effects, including sleep disturbance, appetite
suppression, and cardiac events (National Institute of Mental Health, 2012). Further,
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there are different side effects depending on how the medication is ingested, including
hallucinations, seizure, and stroke (NIDA, 2011).
Academic Risks
There are also a number of academic risks related to IUPS. The effect of
prescription stimulant medications on those without ADHD is not always positive (Barch
& Carter, 2005; Lakhan & Kirchgessner, 2012), and IUPS can be related to poor
academic outcomes, including skipping class and studying less (Arria, O’Grady,
Caldeira, Vincent, & Wish, 2008). Further, many universities have begun to include
language to codes of conduct barring any unauthorized or improper assistance, which
could include IUPS (Gardner, 2011). Also, many universities are changing the
requirements for obtaining prescription stimulant medications at university health centers,
including requiring a signed no-misuse contract, a full-hour check-up each month,
completing a full and thorough assessment, and learning specific coping skills related to
symptoms of ADHD (Schwarz, 2013). College administrators are hoping to decrease the
ease of availability of prescription stimulant medications for students who may engage in
any kind of IUPS (Schwarz, 2013).
Legal Risks
Although not frequently considered, there are a number of legal risks related to
engaging in IUPS. Prescription stimulant medications are considered Schedule II
substances, which means they are intended to be highly regulated due to the high
potential for abuse (United States Drug Enforcement Administration, n.d.). As with other
kinds of prescription medications, possession without a prescription or distribution of
5

prescription stimulant medications can result in serious legal consequences, including
fines or even prison sentences.
However, although the aforementioned legal risks are a possibility, many college
campuses focus instead on the more prevalent issues of other drug use, specifically
including risky drinking behaviors, which has entire organizations focused on prevention
programs solely related to drinking behaviors (National Institute on Alcohol Abuse and
Alcoholism, n.d.). This is corroborated by students’ willingness to discuss engaging in
IUPS with researchers (DeSantis & Hane, 2010) and even on social media (Hanson et al.,
2013).
Social Risks
Further, social risks related to engaging in IUPS have not been frequently
discussed in the literature. Most discussions of social risk have related to how IUPS is
often perceived to be an ethical and socially acceptable behavior (Judson & Langdon,
2009).
Disapproval ratings for engaging in IUPS have recently decreased among
emerging adults. Monitoring the Future, an ongoing nationwide study looking at different
kinds of substance use among high school and college students (MTF; Johnston et al.,
2015), asks about participants’ disapproval of different kinds of licit and illicit drug use.
In 2011, the questionnaire was updated to include use of Adderall and Ritalin under a
broader category of amphetamine use, decreasing the focus on illicit amphetamines. In
2014, for participants ages 19 to 22, 73.6% reported disapproving of trying
amphetamines (e.g., Adderall, Ritalin, speed, or uppers) once or twice. This was a 10.0%
decrease from 2013, showing a significant decline in disapproval among this age group.
6

For comparison, the disapproval rates for other behaviors include 64.7% for drinking five
or more alcoholic drinks during the weekend, 71.3% for smoking marijuana regularly,
and 80.6% for smoking a pack or more of cigarettes per day. Although the disapproval
ratings for using amphetamines regularly is still high (92.8%), the decrease in disapproval
for trying amphetamines once or twice suggests that emerging adults are increasingly
approving of experimenting with prescription medications like Adderall or Ritalin.
One further limitation of this finding is the inclusion of street names of
amphetamines. The MTF study did not separate out Adderall and Ritalin (i.e., types of
prescription stimulant medication) from “speed” and “uppers” (i.e., street names for
amphetamines). Thus, it seems plausible that disapproval for only IUPS may be lower
than for illicit street drugs. Street names may imply more recreational intent, whereas
college students may conceptualize the use of Adderall or Ritalin as more commonly
used for academic purposes, particularly as improving academics is the most commonly
reported motivation for IUPS (Hartung et al., 2013; Rabiner et al., 2009).
Theoretical Explanations of IUPS
One recent goal of the literature in this area is to better understand the different
reasons why college students may be engaging in this behavior. There are a number of
theories that address why people engage in prescription drug abuse.
Strain Theory
One theoretical explanation for IUPS draws on Strain Theory. Although Strain
Theory has not typically been used as a theory to explain illicit drug use, it fits
particularly well with the concept of IUPS. Strain Theory, initially proposed and revised
7

by Agnew (1992) but later utilized by Ford and Schroeder (2009) to explain IUPS,
discusses three possible sources of strain. The first possible source of strain is when one
does not achieve a desired goal. For college students, this would likely relate to lack of
academic success (e.g., failing a class, getting a poor grade on an assignment). The
second possible source of strain is when one loses some kind of positive stimulus. For
college students, this would likely relate to loss of something, such as scholarship
funding or poor grades. The third possible source of strain is when one gains an unwanted
stimulus. For college students, this could relate to poor interactions with other students or
faculty, or as Ford and Schroeder suggest, even poor grades. However, it appears that
Strain Theory may not be the best or most parsimonious explanation for IUPS, as Ford
and Schroeder (2009) found that, although academics may have some connection to
IUPS, academic strain did not directly impact IUPS, but was rather mediated by reports
of negative affect.
Theory of Planned Behavior
One of the more frequently used theories to explain health behaviors is the Theory
of Planned Behavior (TPB). The TPB has been used to explain different kinds of risky or
negative health behaviors, including illicit drug use. In previous studies of TPB and illicit
drug use (including use of cannabis and ecstasy), attitudes strongly predict intentions of
use, and intentions strongly predict actual use (McMillan & Conner, 2003). When
studying illicit drug use, people often report experiencing peer pressure in relation to
using, but TPB’s subjective norms tend to be the least influential than attitudes or
perceived behavioral control.
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Judson and Langdon (2009) used TPB as a guiding theory in their study looking
specifically at IUPS. They focused on student perceptions of IUPS (determining if
students thought that IUPS was safe and ethical), perceptions of others’ perceptions, and
the assumption that stimulant medication would help control behavior. The study found
that illicit users shared attitudes and normative beliefs about IUPS. Although the TPB is
useful in connecting perceptions of use with actual behaviors, the theory itself does not
necessarily separate different kinds of perceptions, including perceptions of benefits or
risks.
Health Belief Model
The Health Belief Model (HBM) has been used to try to explain and predict
behavior, specifically related to health behaviors. The HBM has four main concepts:
perceived susceptibility, perceived severity, perceived benefits, and perceived barriers
(Janz & Becker, 1984). Perceived susceptibility relates to one’s perceptions of the risks
related to side effects and the likelihood of the side effects occurring. Perceived severity
relates to the perception of the seriousness of the side effects. Perceived benefits and
perceived barriers relate to the idea of a cost-benefit analysis in relation to deciding
whether to engage in a behavior, as there are both benefits (at least perceived benefits,
including possible academic success, appetite suppression, being able to better focus) and
barriers (cost, accessibility, possibility of negative side effects) related to engaging in
IUPS (Janz & Becker, 1984). Although the HBM has been used to explain different kinds
of risky health behaviors, including safe sex behaviors like HIV prevention and carrying
condoms, it has not been extensively used in the field related to illicit drug use, let alone
IUPS.
9

The HBM fits well with attempting to explain IUPS. College students have lower
perceived susceptibility and lower perceived severity related to the risks related to IUPS,
specifically low perceived harmfulness and low expectations of possible risks related to
IUPS (Arria et al., 2008b). Although research has shown that IUPS has fewer benefits
than most think, college students likely perceive stimulant medication to be helpful in
improving academics, which is the most commonly reported motivation for IUPS. Lastly,
the perceived barriers to IUPS are not insurmountable or even daunting. The availability
of prescription stimulant medications on college campuses has increased greatly since the
1990’s (Kaye & Darke, 2012) and the street price for most stimulant medications is under
$10 (Partnership for Drug-Free Kids, 2015). Thus, although the HBM has not been used
directly to attempt to explain IUPS, it is a promising theory for a concise yet thorough
explanation of why college students may engage in IUPS.
Theory of Triadic Influence
The theory most directly related to this project is the Theory of Triadic Influence
(TTI). The TTI has been used in the past to explain risk and protective factors of alcohol
and tobacco use among youths (Flay, Phil, Hu, & Richardson, 1998; Flay, 1999), but
more recently has been used to delve into different factors related to IUPS (Bavarian et
al., 2013). The TTI is a more comprehensive theory that covers a number of possible
influences (Flay, Snyder, & Petraitis, 2009). The TTI includes three streams of influence,
including intrapersonal, social context, and sociocultural environment. The intrapersonal
stream of influence includes one’s characteristics that relate to self-efficacy; examples of
this include self-esteem and self-regulation. The social context stream of influence
includes one’s social situation that may affect how one behaves or one’s beliefs about
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behaviors; examples of this include parenting styles and one’s normative beliefs. The
sociocultural environment stream of influence includes larger environmental factors that
affect behavior; examples of this include culture and socioeconomic status. Further, the
TTI includes three levels of causation, including ultimate, distal, and proximal (Flay et
al., 2009). The ultimate level refers to more longstanding and underlying causes, like
culture or neighborhood poverty. The distal level refers to causes that may be mediated
through other variables, whereas the proximal level refers to causes that have a more
direct effect on behavior.
Although the TTI is a useful and comprehensive theory that provides valuable
information for conceptualizing IUPS, the extensive nature of the TTI (i.e., the nine
possible combinations of streams of influence and levels of causation needing to be
represented) likely requires any use of this theory to include a comprehensive and long
list of questions and variables. This may not be of use for all clinical or research
purposes, or for determining the best predictors of IUPS.
Benefits of the HBM
A more appropriate theory to use for the purposes of this project is the Health
Belief Model. Although the HBM has not been used regarding IUPS, it may provide the
framework for a more parsimonious explanation of IUPS, with specific focus on
perceived susceptibility and perceived benefits. However, one aspect of the TTI which
will likely be helpful in specifically predicting IUPS will be the concept of levels of
causation, as defined by the TTI, particularly looking at distal and proximal level
predictors. Distal and proximal predictors are often discussed in terms of relation to an
individual (Lammle, Woll, Mensink, & Bos, 2013); the biopsychosocial model defines
11

distal predictors as being more related to one’s environment and other individuals (e.g.,
normative societal beliefs of IUPS or availability based on location or university).
Proximal predictors are typically more closely related to the individual (e.g., risk
perception, past drug use). However, different constructs can be measured on multiple
levels of proximity (e.g., risk perception as measured by one’s own beliefs (proximal) or
their knowledge of a friend experiencing some negative outcome (proximal) versus an
individual knowing someone at another school who experienced a negative outcome
(distal). Thus, attempts to best understand IUPS may be best served by using a
combination of the HBM and TTI.
Previous Measurement of IUPS
IUPS has been measured frequently in the literature, but there have been few
attempts at a standardized form of measuring IUPS.
Stimulant Survey Questionnaire
One of the earlier attempts at a standard questionnaire measuring IUPS was the
Stimulant Survey Questionnaire (SSQ; Weyandt et al., 2009). The SSQ was created as a
measure of both medical and non-medical use and related constructs, such as attitudes
about stimulants and knowledge about stimulants on campuses. The SSQ includes many
items measuring motivations, asking participants about specific motivations. The SSQ
consists of four factors: (1) self-reported stimulant use, (2) perception of prevalence
among peers, (3) knowledge of atypical stimulant use among peers, and (4) perception of
safety of stimulants. The four factors in total accounted for roughly 51% of the variance.
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The SSQ covers many constructs to be measured in relation to IUPS (e.g., route
of administration, motivations, perceived harm, perception of availability, etc.), but lacks
specificity in measuring constructs other than motivation. Specifically, the SSQ lacks
specificity in terms of measuring specific thoughts related to use (e.g., the type of risk
involved) and specific behaviors of use (i.e., misuse, consumption, diversion). The only
psychometrics available for the questionnaire were the internal consistency ratings for the
entire questionnaire and then for each of the factors. Overall, the Cronbach’s alpha for the
questionnaire was .849, with the internal consistency for each factor as follows: Factor 1
at .923, Factor 2 at .434, Factor 3 at .613, and Factor 4 at .608.
National Survey on Drug Use and Health
Another frequently cited questionnaire is the National Survey on Drug Use and
Health (NSDUH) series of surveys (Center for Behavioral Health Statistics and Quality,
2015). The NSDUH questionnaires involve a nationwide study of individuals 12 years
and older. The questionnaire uses an interview format, and has numerous questions about
many different kinds of drugs, one of which being prescription stimulant medications.
However, the NSDUH questionnaire asks participants to report if they have ever used
stimulants for the experience or feeling it causes, and does not differentiate between
prescription stimulant medications and illicit stimulants (e.g., methamphetamine).
Further, the NSDUH questionnaire does not go beyond the scope of prevalence, duration,
and frequency, and thus does not gather information regarding perceptions or motivations
regarding prescription stimulant medications.
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College Life Study
Another attempt to study IUPS is the College Life Study (CLS), conducted
through the University of Maryland. The CLS is a longitudinal, prospective study of a
large cohort of college students. The study included an initial screening of first-year
students and has included follow-up measures and interviews with this select cohort. The
study asked about a broad range of topics, including types of illicit drug use, social
functioning, and mental health. The questions used by the CLS relating to IUPS were
modeled after questions adapted from NSDUH.
The CLS has resulted in a number of individual studies looking at different
correlates of IUPS. IUPS was shown to be associated with energy drink usage later in
college (Arria et al., 2010), with symptoms of ADHD (Arria et al., 2011), with lower
grade point averages (Arria et al., 2008c), with other kinds of illicit drug use (Arria et al.,
2008a), and with previous alcohol and marijuana use (Arria et al., 2013). Further, low
perceived harmfulness of IUPS was shown to be a significant predictor of IUPS using a
logistic regression model (Arria et al., 2008b). Although the CLS has resulted in a
number of useful findings regarding IUPS, it is not a comprehensive measure of different
possible predictors of IUPS.
BEACH-Q
The most comprehensive measure of IUPS to date is the Behaviors, Expectancies,
Attitudes and College Health Questionnaire (BEACH-Q). The BEACH-Q was developed
by Bavarian and colleagues (2013) in an attempt to best detail and predict “prescription
stimulant misuse.” The process of development of the BEACH-Q had five separate
development stages, including review of the instrument by college students and health
14

professionals, as well as pilot testing and a complete campus study (Bavarian et al.,
2013). The survey was developed using the Theory of Triadic Influence (TTI), discussed
earlier, in an attempt to cover multiple aspects of possible influences.
Included in the intrapersonal stream of influence were items related to
demographic factors, ADHD diagnosis, and factors related to academics, as well as items
related to participants’ avoidance self-efficacy in relation to avoiding misuse of
prescription stimulant medications. The social context stream of influence included items
related more to the participant’s social environment, including extracurricular activities
on campus and relationships. The sociocultural environment stream of influence included
items related to the perceived culture on the campus, as well as expectations regarding
prescription stimulant medications.
Throughout the development of the BEACH-Q, the psychometric properties of
the measure were determined in various ways. The BEACH-Q demonstrated good
content validity, indicating that health professionals reported that items seemed to match
content with their concept of what was being asked, with the median scores being
between “agree” and “strongly agree.” Face validity was similarly measured, but with
college students instead of health professionals, and all items were considered by the
college students to be face valid and “straightforward.” Finally, internal consistency
reliability was determined to be moderate to high (above .50), with some covariates being
higher than others, and stability reliability was determined to be modest to high (above
.30), again depending on the covariate. The BEACH-Q was revised and presented in
Bavarian et al., 2014, with updated reliability information. Internal consistency reliability
for the constructs including multiple items in the revised BEACH-Q was higher than in
15

the original BEACH-Q, with the lowest reliabilities at 0.64 (study habits) and 0.66
(sensation seeking). The rest of the constructs had reliability of 0.79 or better.
The limitations of the BEACH-Q discussed in the initial article (Bavarian et al., 2013)
consisted mostly of the possibility of useful items being excluded, specifically related to
diversion of prescription stimulant medications.
The BEACH-Q has thus far been the most comprehensive attempt to determine
the greatest predictors of IUPS. However, although the BEACH-Q is highly
comprehensive, there are factors that are excluded from the BEACH-Q but have been
shown in other studies to have possible predictive value.
The main part missing from the BEACH-Q is the inclusion of more variety for
perceived harm of IUPS. Perceived harmfulness has been shown to be predictive in terms
of IUPS, with lower perceived harmfulness being related to IUPS (Arria et al., 2008b).
Although the original BEACH-Q includes one item regarding the possible harm of
prescription stimulant medication, it does not specifically ask about the potential harm of
IUPS, and only asks whether participants believe that prescription stimulants are
“harmful to the body.” This item was left out of the revised version of the BEACH-Q.
The literature in the area has focused on a global definition of risk or harm, with studies
asking about an overall harmfulness (Arria et al., 2008b). However, this may not
represent the full picture of how participants perceive risk. If separated into different
domains (i.e., legal, health, and social risk), participants may report different perceptions
of different kinds of risk. Specifically, participants with greater knowledge of negative
health side effects are not less likely to engage in IUPS (Bavarian et al., 2013). However,
there may be a different effect for types of harm other than “to the body.” Further, there
16

are some gender differences in perceptions of risk (Hachtel, 2015). In sum, looking at an
overall perception of risk or harm may not tap into the variation or different facets of risk
or harm.
Although the risks related to IUPS are well-known, college students’ perceptions
of those risks are not frequently studied, or, if studied, are studied in limited ways. In
terms of knowledge of health risks, Judson and Langdon (2009) found that participants
who reported IUPS had more knowledge of the possible negative side effects of stimulant
medications. Illicit users are also more likely not to consider IUPS a socially risky or
socially unacceptable behavior (Judson & Langdon, 2009). Further, believing that others
are socially accepting of IUPS and engage in it themselves is also a risk factor for
engaging in IUPS (Kilmer et al., 2015). Beyond overall beliefs regarding IUPS, college
students have fewer negative beliefs about IUPS when relating to using prescription
stimulant medications as study aids when compared to other motives, like recreational
uses or appetite suppression (Lookatch, Moore, & Katz, 2014).
Although many of the theories used to explain IUPS, including the HBM and TTI,
provide opportunity to include risk perception as part of a theory-driven explanation of
IUPS, there has been a lack of research relating to detailed risk perception in the
literature. The TTI provides a framework for asking about multiple different kinds of risk
through the different streams of influence (e.g., asking about social risk through the social
context stream of influence by discussing normative beliefs), but there were no specific
risk questions asked in the revised BEACH-Q. Further, the HBM fundamentally includes
a discussion of risk perception (i.e., perceived susceptibility); however, there have not
been studies specifically using the HBM to attempt to explain IUPS.
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Another limitation of the BEACH-Q is based on timeframes included in analyses.
The items in the BEACH-Q ask specifically about different kinds of IUPS during college.
Although using a shorter timeframe than lifetime prevalence may be a more accurate
portrayal of recent behavior and would likely be more helpful in informing prevention or
intervention programs, “during your time in college” can mean vastly different time
frames for students depending on their year in school (i.e., for freshmen, this likely means
no more than one year, whereas for seniors, this can cover anywhere between past month
and past four years).
One final concern regarding the BEACH-Q is that it has 100 items and is thus not
efficient for completing quickly. If a briefer but still psychometrically valid measure of
IUPS could be developed, it seems reasonable to speculate that a wider variety of uses for
such a measure could be found.
The Current Study
Thus, the current study aimed to build on the work of Bavarian and colleagues to
create a brief yet comprehensive measure to best predict IUPS. The project’s research
questions were as follows:
1. How will the BEACH-Q function with this project’s sample in comparison to the
sample from Bavarian et al., 2014?
a. How much variance of IUPS will the BEACH-Q explain for our sample?
i. Hypothesis: The BEACH-Q will explain a similar amount of
variance for our sample when compared to the initial variance
explained by Bavarian and colleagues (2014).
b. How much variance will the new items explain for our sample?
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i. Hypothesis: The new measure items will explain a similar amount
of variance when compared to the variance explained by the
BEACH-Q.
2. How can we create a short-form measure that effectively and concisely explains
IUPS?
a. Will there be particular items or constructs that are especially helpful in
explaining variance?
b. How will a created short-form measure compare to the original BEACH-Q
explanation of variance?
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METHOD
Participants
Research in this field mostly revolves around the study of college students,
particularly because this behavior is so prevalent on college campuses. This study
continued this trend and used college students as participants in assisting with the
development of this measure. Participants were recruited through the Psychology
Research Pool (PRP) at Mississippi State University.
A power analysis was conducted using G*Power (Faul, Erdfelder, Buchner, &
Lang, 2009) for analyses related to the short-form measure (i.e., logistic regression). The
suggested sample size was 337. Additional participants were added because of the rate of
prevalence for consumption (24.1% reported prevalence in an MSU sample previously,
so 81 participants added; Hachtel, 2015) and further participants were added to account
for possible dropout or invalid responses (20% added, so 83 participants added). The
number of participants recruited through the PRP was 501. This sample size was
sufficient for the initial analyses conducted to determine variance (i.e., exploratory factor
analyses), as one review reported roughly 40% of articles using factor analyses using a
subject to item ratio of 5:1 or less (Costello & Osborne, 2005). With this sample size and
the number of proposed items for the analyses, the subject to item ratio would be roughly
2.5:1.
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Exclusionary criteria initially included advertising the survey to participants over
the age of 18 years old and under 25 years old to decrease the chances of losing
anonymity. Further, most of the literature in this field includes only individuals between
the ages of 18 and 25. However, Bavarian and colleagues did not exclude participants
based on age, and thus, analyses were run for this study including all participants who
validly completed the survey. This meant including the 2 participants who reported ages
over 25 even though the study specifically solicited people between the ages of 18 and
25.
Initially, there were 1,438 responses to the survey. Although the power analysis
suggested recruiting a minimum of 501 participants, more data were collected for the
purpose of running further analyses in future projects. Of 1,438 responses, 31 were
discarded due to participants completing 20 percent or less of items in the measure, not
including items left out due to branching. This left 1,407 participants. Finally, the data set
was split in half to reserve data for future analyses. Thus, the final analyzed sample
consisted of 703 participants.
The sample consisted of 267 men (38.0%) and 426 women (60.6%), with 10
participants (1.4%) missing a response. Most participants identified as White or
Caucasian (490, 69.7%), with 163 (23.2%) participants identifying as Black or African
American and 42 participants (6.0%) identifying as another race (e.g., Asian, Hispanic,
multiracial, etc.). The mean age of the sample was 18.84, with a standard deviation of
1.35. The breakdown of class standing of participants was as follows: 521 (74.1%)
freshmen, 74 (10.5%) sophomores, 46 (6.5%) juniors, 52 (7.4%) seniors, and 1 (0.1%)
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unclassified or graduate. Lastly, our sample had a large proportion of participants
identifying as Greek-affiliated (256, 36.4%).
Procedure
Participants accessed the survey through the Psychology Research Pool (PRP)
through Mississippi State University. The PRP is used to help recruit students for
research projects. Through this program, students complete studies for either class credit
or extra credit opportunities. For a questionnaire with a median response time of 23
minutes, participants received 0.5 credits upon submission of the questionnaire.
Participants accessed the survey through the PRP website, where they had
multiple options for possible studies to take or alternative activities to complete. Upon
selection of this questionnaire, participants were redirected to the Qualtrics platform,
where they read an informed consent document. As the study took place online, signed
consent forms were not collected, and participants were considered consenting if they
selected that they agreed to participate and continued with the study. Participants were
informed that they could drop out of the study at any time if desired.
Participants first completed the BEACH-Q measure. Then, participants completed
the additional questions added, as discussed below. There were certain items overlapped,
including demographic items and intentions of IUPS, to make it possible to use each
measure (i.e., separating the BEACH-Q and the second measure) completely
independently.
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Measure Creation
This measure was created as an attempt to best predict IUPS among college
students. The literature of the field was reviewed and predictors included in the literature
are reviewed below. For complete questionnaire, please see Appendix A.
IUPS
As discussed previously, IUPS has been defined in a number of ways, including
breaking down specific behaviors (e.g., consumption, misuse, diversion) and using an
umbrella term (e.g., IUPS to describe all three of the behaviors). Due to the debate of
how to define different kinds of IUPS, this project asked participants about specific
behaviors (e.g., have you ever consumed someone else’s prescription stimulant
medication (whether you had a prescription of your own or not)) and then those items
were labeled to reflect the specific labels (e.g., consumption). This also made it clear
which behaviors were being included with which terms.
Participants were asked about a number of behaviors during a number of time
frames. Branching was used through Qualtrics to prevent participants having to answer
questions in a redundant manner. Specifically, if a participant answered “no” to ever
engaging in the behavior during their lifetime, they were redirected to the next set of
questions, rather than having to answer “no” for the behavior in each time frame. The
time frames included during their lifetime, during college, in the past year, and the past
month. Participants were also asked how frequently they had engaged in the behavior
during each time frame.
The specific behaviors of IUPS that were measured are as follows: misuse,
consumption, and diversion. Misuse was measured by asking participants if they had
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taken a larger or more frequent dose than prescribed; only participants with current or
past prescriptions were asked if they have misused their prescription. Consumption was
measured by asking participants if they had consumed someone else’s prescription
stimulant medication (whether they had a prescription of their own or not); all
participants were asked to answer questions about consumption. Finally, diversion was
measured by asking participants if they had sold, shared, or traded prescription stimulant
medication; participants did not need to have a current or past prescription to respond to
items related to diversion. Although these specific behaviors were measured, they were
also combined into a variable of overall lifetime IUPS, indicating that participants had
endorsed any of the previously mentioned behaviors.
ADHD Symptoms
To measure symptoms of ADHD, the Adult ADHD Self-Report Scale (ASRS)
was included. Although the BEACH-Q includes three symptoms of inattention and three
symptoms of hyperactivity/impulsivity, the ASRS was included because of its ability to
function either as a continuous or categorical measure, enhancing possible analyses. In an
adolescent sample, the ASRS showed high internal consistency (a = 0.93) and high
concurrent validity (Adler et al., 2012). Further, the ASRS has shown utility in
identifying college students who may benefit from assessment of ADHD symptoms
(Garnier-Dykstra, Pinchevsky, Caldeira, Vincent, & Arria, 2010). ADHD symptoms were
measured as two sets of variables: one continuous variable of the total ASRS score
(ranging from 0 to 72) and two categorical variables of whether the participant meets the
cut-off score for significant inattention or hyperactive symptoms.
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Risk Perception
As mentioned in the introduction, perceived harmfulness has been shown to be
related to IUPS. Participants with lower perceived harmfulness of engaging in IUPS were
roughly 10 times as likely to have engaged in IUPS in the previous year (Arria et al.,
2008b). However, one of the limitations of that study is the general definition of
perceived harmfulness. The items asked included vague terminology about harm,
providing “physically or in other ways” as the only prompt. However, there is utility in
breaking down the perception of risk or harm related to IUPS into different areas of risk.
Specifically, social risk perception is rated lower than legal or health risk perception, and
those who have engaged in consuming someone else’s prescription stimulant medication
report lower risk perceptions than those who have not engaged in IUPS (Hachtel, 2015).
Further, the little previous research has focused solely on self-report of
perceptions of risk. However, based on the theories discussed previously, proximal
characteristics and behavioral markers can be most helpful in predicting behavior. Thus,
the developed measure included questions about knowledge of others’ outcomes related
to risk (e.g., “Do you know someone personally who has gotten into legal trouble due to
illicit use?”) and questions about changes in behavior because of risk perception (e.g.,
Have you ever stopped or reduced illicit use of stimulant medication because of possible
legal trouble?). Questions were included for legal, health, and social risk, as well as items
related to possible academic consequences.
Risk perception scores were measured as a continuous variable, ranging from a
score of 1 (not risky at all) to 4 (very risk), so that lower scores represented lower
perceived risk. Separate questions were asked for legal risk, health risk, and social risk,
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and those risk questions were asked regarding misuse of one’s own prescription stimulant
medication (i.e., taking a larger or more frequent dose), consuming someone else’s
prescription stimulant medication, and diverting (i.e., sharing, selling, or trading)
prescription stimulant medication.
Further, to attempt to include both proximal and distal predictors of risk
perception, participants were asked about their experience with and knowledge of
negative outcomes of engaging in IUPS. These questions were further broken down into
negative legal, academic, health, and social outcomes. Participants were asked if they
know someone personally who has experienced a negative outcome, if they know
someone at their own school who has experienced a negative outcome, and if they know
someone at another school who has experienced a negative outcome. These were
measured as a categorical variable, with participants responding “yes” or “no.”
Intentions of IUPS
In the creation of the BEACH-Q, Bavarian and colleagues (2013) adapted an item
from previous surveys to determine participants’ intentions of engaging in IUPS. The
original item in the BEACH-Q inquired about intentions of engaging in prescription
stimulant misuse during college, and the item was adapted for this questionnaire to fit
with the definitions of terms used. Participants were asked how likely it is that they will
engage in IUPS (defined in the item as consumption, or consuming without a
prescription) while in college, with response options ranging from 1 (very unlikely) to 4
(very likely).
The original items in the BEACH-Q were also presented during the BEACH-Q
portion of the survey. The BEACH-Q includes three items scored from 1 (definitely
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won’t) to 5 (definitely will) and asks participants how likely it is that they will use
stimulants without a prescription, for nonmedical purposes, and in excess of what may be
prescribed to them. The original items were presented along with the new item to
determine if responses were consistent in different parts of the measure and to determine
if one item could be as predictive as the three items originally included in the BEACH-Q.
Sensation Seeking
Although not predictive in nature, sensation seeking has been shown to be related
to IUPS (Jardin, Looby, & Earleywine, 2011). Jardin, Looby, and Earleywine (2011)
used the Sensation Seeking Scale (SSS-V), a 40-item measure with high internal
consistency (.91). However, for the sake of developing this questionnaire and with length
in mind, a shorter measure was used to ensure that the questionnaire was not
unnecessarily long. Rather than the 40-item measure, the Impulsive-Sensation Seeking
(ImpSS) subscale of the Zuckerman-Kuhlman Personality Questionnaire cross-cultural
short form (ZKPQ-50-CC) was substituted. The ZKPQ-50-CC is a revised version of the
original and short-form ZKPQ and has been validated across a number of cultures and
languages (Aluja et al., 2006). The ZKPQ-50-CC has similar psychometric properties as
the original ZKPQ. Specifically, the subscale used in this measure, the ImpSS, has a
mean score of 6.00 (SD = 2.55) and adequate internal consistency reliability (a = 0.72)
for participants from the United States.
Positive Expectancies
To measure expectancies of what will occur during or after IUPS, the Prescription
Stimulant Expectancy Questionnaire-II was included. The PSEQ-II was developed to
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measure different expectations of prescription stimulant medications, including both
positive expectations (e.g., I can study/work for hours, distractions disappear) and
negative expectations (e.g., I feel sick to my stomach, I get nervous and edgy). The
PSEQ-II includes 45 items scored on a scale with response options including 0 (not at
all), 1 (sometimes), and 3 (very often or always). The positive expectancies included two
factors, Cognitive Enhancement (a = 0.95) and Social Enhancement (a = 0.87), and the
negative expectancies included two factors, Anxiety and Arousal (a = 0.89) and Guilt
and Dependence (a = 0.77) (Looby & Earleywine, 2010). During the factor analysis
conducted to determine the factor loadings, the total variance explained by the four
factors was 48.97%. The Cognitive Enhancement factor was significantly positively
correlated with IUPS in the past month, whereas the Anxiety and Arousal factor and the
Guilt and Dependence factor were significantly negatively correlated with IUPS in the
past month. The variables included in analyses were the continuous variable of positive
expectancies and the continuous variable of negative expectancies.
History of Other Drug Use
Although not always discussed as predictive, history of other drug use and illicit
drug use has been shown to be related to IUPS (Jardin, Looby, & Earleywine, 2011).
Further, use of other substances, particularly energy drinks, has been associated with
IUPS (Arria et al., 2010). As energy drinks and other substances containing stimulants
(e.g., nicotine products, coffee, etc.) could be used to gain similar outcomes as taking a
stimulant medication (e.g., improving focus, staying awake), we were interested to see if
conceptualizing drug or substance use as a coping mechanism could help predict IUPS.
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Participants were asked if they have used the following substances: energy drinks,
nicotine (e.g., cigarettes, chewing tobacco, vaping), alcohol, marijuana, cocaine,
amphetamines (e.g., speed, uppers, bennies), hallucinogens (e.g., LSD, PCP, salvia,
ketamine, etc.), prescription opiates (e.g., OxyContin, Percocet, Vicodin) without a
prescription, and prescription sedatives (e.g., tranquilizers or depressants) without a
prescription. Similar to how IUPS was measured, participants were asked if they have
ever used each substance, whether they have used in the past year, and whether they have
used in the past month, depending on their responses (e.g., a participant who answered
that they have never tried marijuana were not asked if they have used marijuana in the
past year or past month).
Knowledge of Others’ Use
Hall and colleagues (2005) ran analyses to determine what factors could be
predictors for IUPS for men and women. They found that, for men, knowing where to
acquire prescription stimulant medication was predictive of IUPS and, for women, have
prescription stimulant medication offered to them was predictive of IUPS. These two
items, along with other select items included in the Hall et al., 2005, article, including
perception of accessibility of prescription stimulant medications knowledge of others’
use, were included in the measure. Questions regarding knowledge of others’ use were
scored on a Likert scale from 1 (strongly disagree) to 5 (strongly agree).
Motivation and Benefit Perception
Judson and Langdon (2009) asked participants to endorse specific motives for
engaging in IUPS, including helping with concentration, staying awake, and getting high.
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Participants who reported engaging in IUPS were more likely to endorse a higher number
of motives when compared to participants who reported never engaging in IUPS. Thus, a
list of possible motivations was included and the total sum of each participant’s endorsed
motivations was used as a continuous predictor variable. Further, as the motivations item
were only answered by those who reported engaging in consumption of someone else’s
prescription stimulant medication, there were also questions assessing the possible
usefulness of prescription stimulant medication (getting at benefit perception by both
users and nonusers), that were answered by all participants.
The benefit perception questions were scored on a scale from 1 (always useful) to
5 (never useful). Benefit perception items covered the same constructs as the motivation
items (e.g., controlling appetite, enhancing exercise, to help concentrate) but included
more variability in responses (continuous rather than categorical).
Statistical Strategy
Statistical analyses were completed using IBM SPSS Version 24.0 (IBM, 2016).
Descriptive statistics were run to determine the demographic characteristics of the sample
collected, including specifically reporting demographic characteristics to match what was
reported in Bavarian et al., 2014 (i.e., race, gender, age, and class standing). Other
demographic characteristics of importance not included in Bavarian et al., 2014, include
Greek affiliation, ADHD diagnosis, and prescription holding. Further, as IUPS was
conceptualized as a combination of consumption and misuse in Bavarian’s article, chisquare analyses were conducted to determine if there are significant differences between
the groups of illicit users (as defined by engaging in consumption and/or misuse, per
Bavarian’s article) and consumers (as defined only by taking someone else’s prescription
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stimulant medication) to determine if IUPS can be comparably used as an outcome
variable (i.e., it is not significantly different than consumption). Although the
measurement of IUPS was similar, Bavarian and colleagues utilized a different time
frame (during college) and did not measure lifetime IUPS. Thus, for the analyses
presented below, it was specifically stated which outcome variable (e.g., IUPS during
college versus IUPS during lifetime) was used for each analysis.
To determine if the BEACH-Q and new measure perform similarly on our
sample, we ran an exploratory factor analysis for both the BEACH-Q and the new
measure to determine how much variance of IUPS is explained by each total measure.
Further, to determine what items would go into a short-form measure, the factor loadings
of the new measure were reviewed to determine which factors were most effective in
explaining the most variance in IUPS, or if specific items would be particularly effective.
Once the short-form measure was selected from the available factors and items, it
was compared to the BEACH-Q and total new measure using a forced binary logistic
regression (the analysis used by Bavarian and colleagues) to determine how the shortform measure performed when compared to the BEACH-Q and the total new measure.
Predictor variables for these analyses included the following: prescription
holding, ASRS screening status, other drug use, knowledge of others’ use, accessibility,
being offered stimulant medication, class standing, gender, Greek affiliation, race, GPA,
risk perception, positive expectancies, negative expectancies, number of motivations
endorsed, benefit perception, intentions of IUPS, and sensation seeking.
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RESULTS
Data Cleaning
Before running analyses, specific items were recoded to aid in creating a total sum
score for the BEACH-Q and sum scores for constructs on the new measure. Specific
items on the BEACH-Q and new measure were recoded so that higher scores on the total
sum score would theoretically represent higher risk for engaging in IUPS. For example,
items asking about the perceived usefulness of stimulant medication were initially coded
using a Likert scale (1 to 5) with lower scores indicating higher perceived usefulness (i.e.,
“always useful”), and were recoded so that higher scores indicated higher perceived
usefulness.
Descriptive Statistics
As one of the aims of this study was to compare the utility of the BEACH-Q from
Bavarian and colleagues’ original work, demographics of the current sample were
reviewed to determine if the demographic makeup was similar or different to Bavarian’s.
The final analyzed sample consisted of mostly White or Caucasian (69.7%), mostly
women (60.6%), mostly freshmen (74.1%), with approximately 36 percent reporting
Greek affiliation.
These demographics differ greatly from the demographics of the sample used in
Bavarian et al., 2013. That sample had a more equal gender breakdown (55.2% women)
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and had more participants identifying as White or Caucasian (79.0%), Asian/Pacific
Islander (8.2%), and Hispanic (5.2%). Further, Bavarian’s sample was more distributed
throughout class standing, with only 12.4% of the sample reporting that they were in their
first year of undergraduate. Lastly, Bavarian and colleagues did not report the breakdown
of Greek affiliation of their sample, though that may not have been a relevant statistic for
their university. Overall, there were considerable differences in demographics between
the two samples.
Hypothesis 1a
A logistic regression was performed to determine the effectiveness of the
complete BEACH-Q measure, including demographics items, on determining the
likelihood of participants ever having engaged in IUPS. Predictor variables included in
the logistic regression were constructs as defined by Bavarian and colleagues, with
demographics also included; however, four items were not included in the logistic
regression, because they were the items used to create the dependent variable of IUPS.
Higher scores on the sum of the BEACH-Q items were associated with higher risk for
lifetime IUPS. The model was significant (c2(92) = 522.355, p < .001), explained 73.3%
(Nagelkerke R2) of variance of IUPS, and correctly classified 91.6% of cases. A logistic
regression was also run for the outcome variable of IUPS during college, to match the
analyses run in Bavarian et al., 2013. However, the logistic regression analysis continued
to abort due to issues with convergence criteria. Thus, this analysis was run with the
predictor variables including a sum total of the BEACH-Q, along with unadded items and
demographics. The model was significant (c2(39) = 380.756, p < .001), explained 67.3%
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(Nagelkerke R2) of variance of IUPS during college, and correctly classified 92.3% of
cases. Given that the logistic regression with the outcome variable of IUPS during college
required using the sum total BEACH-Q score, the logistic regression with the outcome of
lifetime IUPS described above was rerun to use the sum total BEACH-Q score rather
than the individual constructs. The model was still significant (c2(39) = 255.106, p <
.001), but only explained 42.5% (Nagelkerke R2) of variance of IUPS compared to the
original 73.3%, and correctly classified 80.1% of cases, compared to the original 91.6%.
Given this decrease in effectiveness of the model when using the sum total BEACH-Q
score, it is possible that the utility of the measure is not appropriately captured with the
presented analyses.
Further, the analysis in Bavarian et al., 2013, was run on the original BEACH-Q.
The revised BEACH-Q was not utilized until Bavarian et al., 2014, and the analysis was a
regular linear regression predicting IUPS frequency. Bavarian and colleagues (2014) used
SEM to determine an R2 for the outcome variable of IUPS frequency with the updated
BEACH-Q. With the SEM results, Bavarian and colleagues found an R2 of 0.46,
indicating that 46% of the variance was explained.
To best compare the variance explained by the model, a regression was conducted
with the BEACH-Q constructs and demographics as the predictor variables and IUPS
frequency as the outcome variable. For this analysis, the R2 was .789, indicating that
78.9% of the variance of IUPS frequency was explained, which is much larger compared
to the original variance explained with Bavarian and colleagues’ original sample.
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Table 1
BEACH-Q Means and Standard Deviations
Overall
Men
Women

Mean
166.17
167.89
164.50

Std. Dev.
35.93
35.96
35.72

Minimum
92
92
103

Maximum
295
295
290

Hypothesis 1b
A logistic regression was performed to determine the effects of the new measure
items, including demographics items, on the likelihood of participants ever having
engaged in IUPS. This analysis included all items and constructs included in the initial
stages of the new measure other than items asking about detailed IUPS behaviors (i.e.,
148 items). The model was significant (c2(28) = 755.490, p < .001), explained 92.9%
(Nagelkerke R2) of variance of IUPS, and correctly classified 97.4% of cases.
Hypothesis 2
The main goal of this project was to take the large amount of new measure items
and decrease them into a brief, efficient short-form measure. The initial attempt to run the
EFA analysis on all 199 items resulted in a factor structure, but the determinant value
(5.26E-092) provided within the correlation matrix suggested that multicollinearity
within the data may be an issue. To help decrease the amount of items and decrease
multicollinearity, factor scores below 0.7 were suppressed and removed in subsequent
analyses, and the eigenvalue cut-off for factors was increased from one to two. Removing
items with factor loadings below 0.7 removed a total of 98 items, leaving 101 items still
with high multicollinearity. Next, the correlation matrix provided in the EFA analysis
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was used to identify pairs of items that were highly correlated. These pairs were analyzed
to determine which item in each pair would be most appropriate to delete, using factor
loadings (i.e., the item with a lower factor loading was deleted, and if the factor loadings
were approximately the same, the decisions were based on evidence in the literature).
Seventeen items were deleted for being correlated above 0.9, 20 items were deleted for
being correlated above 0.8, 17 items were deleted for being correlated above 0.7, and 26
items were deleted for being correlated above 0.6. Multicollinearity was checked at each
stage, and the determinant was an appropriate value (.003) after items correlated above
0.6 had been removed. However, after removing the highly correlated items, the items
did not appear to be loading well onto the factors being forced. Thus, the eigenvalue
cutoff was dropped back down to one and factor scores were not suppressed in an effort
to provide the items more flexibility in factor structure. The resulting analysis showed a
six factor structure, but with six items loading poorly (0.5 or below) onto factors. The
final analysis consisted of 15 items loading onto five factors, and explained 69.92% of
variance. For items included in the data-driven EFA, please see Appendix B.
Table 2
Data-Driven Short-Form Means and Standard Deviations
Overall
Men
Women

Mean
32.42
32.33
32.46

Std. Dev.
5.82
5.83
5.86

Minimum
17
17
19

Maximum
49
48
49

Factor Structure of the Data-Driven Short-Form
The final data-driven EFA resulted in five factors. Factor 1 was labeled “ADHD
Symptomology” and included the following items originally from the ASRS:
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•

“How often do you have difficulty concentrating on what people say to
you, even when they are speaking to you directly?”

•

“How often do you make careless mistakes when you have to work on a
boring or difficult project?”

•

“How often do you have difficulty getting things in order when you have
to do a task that requires organization?”

•

“How often do you have difficulty unwinding and relaxing when you have
time to yourself?”

•

“How often do you have difficulty waiting your turn in situations when
turn taking is required?”

Factor 2 was labeled “Knowledge of Others’ Negative Consequences” and
included the following items:
•

“Have you heard of someone at your school who has experienced a
negative health event due to illicit use?”

•

“Have you heard of someone at your school who has gotten into legal
trouble due to illicit use?”

•

“Have you heard of someone at your school who has experienced social
rejection due to illicit use?”

•

“Have you heard of someone at another school (not the school you attend)
who has gotten into academic trouble due to illicit use?”

Factor 3 was labeled “Risk Perception of IUPS” and included the following items:
•

“How much of a legal risk is posed by consuming someone else’s
prescription stimulant medication?”
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•

“How much of a health risk is posed by diverting prescription stimulant
medication?”

Factor 4 was labeled “Negative Expectancies of Prescription Stimulants” and
included the following items:
•

“My heart races”

•

“I feel sick to my stomach.”

Lastly, Factor 5 was labeled “Perceived Availability of Stimulant Medication”
and included the following items:
•

“Stimulants are as easy to get as alcohol”

“I know students on campus who take stimulants for nonmedical purposes.”
Table 3
Factor Structure of the Data-Driven Short-Form
Factor
1
23.91
.851

Explained variance (%)
a
Items
How often do you have difficulty
concentrating on what people say to you,
even when they are speaking to you
directly?
How often do you make careless mistakes
when you have to work on a boring or
difficult project?
How often do you have difficulty getting
things in order when you have to do a task
that requires organization?
How often do you have difficulty
unwinding and relaxing when you have
time to yourself?

.818

.794
.791
.779
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Factor
2
15.95
.812

Factor Factor Factor
3
4
5
11.78 10.27 8.01
.721
.724
.745

Table 3 (continued)
How often do you have difficulty waiting
your turn in situations when turn taking is
required?
Have you heard of someone at your school
who has experienced a negative health
event due to illicit use?
Have you heard of someone at your school
who has gotten into legal trouble due to
illicit use?
Have you heard of someone at your school
who has experienced social rejection due
to illicit use?
Have you heard of someone at another
school (not the school you attend) who has
gotten into academic trouble due to illicit
use?
How much of a legal risk is posed by
consuming someone else’s prescription
stimulant medication?
How much of a health risk is posed by
diverting prescription stimulant
medication?
My heart races.
I feel sick to my stomach.
Stimulants are as easy to get as alcohol.

.773
.828
.807
.783
.778

I know students on campus who take
stimulants for nonmedical purposes.

.887
.879
.883
.880
.910
.865

Logistic Regression With the Data-Driven Short-Form
A logistic regression was run to determine how well the data-driven short-form
measure would predict IUPS. The predictor variables included the factor scores created
for each factor, and the outcome variable was IUPS. The model was significant (c2(5) =
114.623, p < .001), explained 21.0% (Nagelkerke R2) of variance of IUPS, and correctly
classified 74.8% of cases.
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Hand-Picked Short-Form
Although the data-driven EFA yielded a brief measure with good predictive
ability, it included multiple items relating to the same construct (e.g., five items relating
to ADHD symptomology, four items relating to knowledge of others’ negative
consequences, etc.) and did not include constructs shown to be critical in previous
literature (e.g., IUPS intentions, stimulus-seeking, etc.). Thus, in addition to the datadriven EFA, a hand-picked measure was also created to determine if a briefer, more
pointed measure would better predict IUPS. The constructs desired for the hand-picked
short from included previous diagnosis, risk perception (Arria et al., 2008b; Hachtel,
2015), other drug use (Arria et al., 2010; Jardin et al., 2011), IUPS intentions (Bavarian et
al., 2013), impulsivity/sensation-seeking (Jardin et al., 2011), gender (McCabe et al.,
2006), and Greek affiliation (DeSantis et al., 2013; Kilmer et al., 2015; McCabe et al.,
2006).
To create the hand-picked short form, items relating to the above constructs were
entered into a logistic regression analysis with IUPS as the dependent variable. The
creation of this measure began with 31 items. The 31-item measure model was significant
(c2(36) = 310.618, p < .001), with 54.1% of variance explained (Nagelkerke R2) and a
classification percentage of 84.7%. However, as the primary goal of this project was to
determine a more concise way to predict IUPS, items were removed to create a shorter
measure. After the initial logistic regression analysis was run, items not significantly
contributing to the model (as determined by the “Variables in the Equation” section of the
output) were removed for the next analysis, with the exception of gender and Greek
affiliation, as these items are consistently included in analyses in the literature. This left
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the hand-picked measure with eight items (see Appendix C for the final hand-picked
short form). The 8-item measure model was significant (c2(10) = 304.806, p < .001), with
50.7% of variance explained (Nagelkerke R2) and a classification percentage of 84.6%.
Table 4
Hand-Picked Short-Form Means and Standard Deviations
Mean
3.99
4.14
3.90

Overall
Men
Women

Std. Dev.
1.84
1.81
1.86

Minimum
2
2
2

Maximum
12
11
12

Factor Structure of the Hand-Picked Short-Form
An exploratory factor analysis was run on the 8-item hand-picked measure to
determine if a valuable factor structure would emerge from the hand-picked items. With a
cut-off eigenvalue of one, three factors emerged; however, the three factors only
explained approximately 53% of variance. Thus, the analysis was rerun with the items
forced into five factors. The five factor model explained 75.29% of the variance.
Factor 1 was labeled “Other Drug Use” and included the following items:
•

“Have you ever tried prescription sedatives (e.g., tranquilizers or
depressants; including Xanax, Valium, Ativan, Ambien, sleeping pills,
yellow jackets) without a prescription?”

•

“Have you ever tried marijuana?”

Factor 2 was labeled “Gender” and included only the following item:
•

“What is your gender?”
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Factor 3 was labeled “ADHD and Greek Affiliation” and included the following
items:
•

“Have you ever been diagnosed with ADHD (AttentionDeficit/Hyperactivity Disorder) or ADD (Attention Deficit Disorder)?”

•

“What is your Greek affiliation?”

Factor 4 was labeled “Impulsivity/Sensation-Seeking” and included only the
following item:
•

“I often get so carried away by new and exciting things and ideas that I
never think of possible complications.”

Factor 5 was labeled “Perceptions and Likelihood of IUPS” and included the
following items:
•

“How much of a health risk is posed by consuming someone else’s
prescription stimulant medication?”

“How likely is it that you will engage in illicit use of prescription stimulant
medication (i.e., using someone else’s prescription stimulant medication) while in
college?”
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Table 5
Factor Structure of the Hand-Picked Short-Form

Explained variance (%)
Items
Have you ever tried prescription sedatives
(e.g., tranquilizers or depressants; including
Xanax, Valium, Ativan, Ambien, sleeping
pills, yellow jackets) without a
prescription?
Have you ever tried marijuana?
What is your gender?
Have you ever been diagnosed with ADHD
(Attention-Deficit/Hyperactivity Disorder)
or ADD (Attention Deficit Disorder)?
What is your Greek affiliation?
I often get so carried away by new and
exciting things and ideas that I never think
of possible complications.
How much of a health risk is posed by
consuming someone else’s prescription
stimulant medication?
How likely is it that you will engage in
illicit use of prescription stimulant
medication (i.e., using someone else’s
prescription stimulant medication) while in
college?

Factor Factor Factor Factor Factor
1
2
3
4
5
23.33 15.14 14.23 11.58 11.01
.805

.783
.894
.876
.580
.981
-.849
-.651

Logistic Regression With Factor Scores
A subsequent logistic regression analysis was completed using the factor scores
from the hand-picked short-form, rather than the total sum, for better comparison to the
analysis conducted with the data-driven short-form. The model was significant (c2(5) =
281.318, p < .001), with 46.6% of variance explained (Nagelkerke R2) and a classification
percentage of 82.3%.
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Comparison to BEACH-Q
Although the data-driven short form and hand-picked short form explained less
variance of IUPS than the BEACH-Q (21.0% and 46.6% versus 74.4%) and had a lower
classification percentage (74.8% and 82.3% versus 91.9%), the BEACH-Q is a lengthy
measure of 100 items and covers multiple constructs possibly unrelated to IUPS. Thus,
each short-form measure can operate as a brief screening measure with only slightly
lower accuracy than the BEACH-Q.
Table 6
Correlation Matrix of Measures

BEACH-Q
DDSF
HPSF.

BEACH-Q

DDSF

.583
.709

.583
.452

HPSF with
Demo.
.709
.452
-

Post-hoc Analyses
Validity
Pearson correlations were conducted between theoretically related constructs to
determine the convergent validity of constructs measured. There was a significant
positive correlation between the new measure of inattention and the BEACH-Q measure
of inattention, r = .535, p < .001, suggesting that participants responded in similar ways
to the two constructs. There was a significant positive correlation between the new
measure of hyperactivity and the BEACH-Q measure of hyperactivity, r = .465, p < .001.
There was a significant positive correlation between the new measure items’ total ASRS
score and the BEACH-Q measure of ADHD-Like symptoms, r = .560, p < .001. There
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was a significant positive correlation between the added items’ measure of impulsivity
and sensation-seeking and the BEACH-Q measure of sensation-seeking, r = .519, p
<.001. There was a significant positive correlation between the new items’ and BEACHQ measure of positive expectancies of IUPS, r = .479, p < .001. There was a significant
positive correlation between the new items’ and BEACH-Q measure of negative
expectancies of IUPS, r = .368, p < .001.
Reliability
There were some inconsistencies in how participants reported their race or
ethnicity. For the item in the new measure, the options given for race included: White or
Caucasian, Black or African American, Asian, Hispanic, Pacific Islander, other, or prefer
not to say. In the BEACH-Q, the options given for race included: White non-Hispanic
(includes Middle Eastern); Black non-Hispanic; Hispanic or Latino/a; Asian or Pacific
Islander; South Asian; American Indian, Alaskan Native, or Native Hawaiian; biracial or
multiracial; and other. It appears that participants may have chosen to identify themselves
in the new measure by the race they felt was the best fit, rather than choosing “other” or
“prefer not to say,” whereas in the BEACH-Q, they were provided with more detailed
and thorough options.
There were also inconsistencies in how participants reported their class standing.
For the item in the new measure, participants were asked to report their class standing
and were given the following options: freshman (first semester), freshman (other than
first semester), sophomore, junior, senior, and unclassified or graduate. In the BEACH-Q,
participants were asked to report their year in school and were given the following
options: 1st year undergraduate, 2nd year undergraduate, 3rd year undergraduate, 4th year
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undergraduate, 5th year or more undergraduate, graduate student, and other. It is likely
that there were some participants who could answer in different ways depending on their
classification. It is possible that some participants may be labeled with a class standing
due to credit hours but have been on campus or in college a different number of years
than expected for traditional class standings.
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DISCUSSION
Major Hypotheses
Although IUPS has been a considerable focus of research in the field of
prescription misuse among college students, there is a lack of consistent and concise
measurement in the field. The main goals of this project were to identify critical
constructs that would best aid in predicting IUPS and identify the most concise form to
maximize predictive capability while minimizing measure length.
Hypothesis 1
The BEACH-Q is a thorough and comprehensive measure of multiple proximal
and distal constructs relating to IUPS. However, the utility of the BEACH-Q is limited
due to the length of the measure and complex nature of the constructs involved. The
BEACH-Q successfully and effectively explained a great amount of variance of IUPS
and was able to classify a vast majority of participants correctly as users versus nonusers. Further, the BEACH-Q actually performed better with the current sample in
explaining variance of frequency of IUPS than the original analyses run by Bavarian and
colleagues, although this comparison cannot be accurately made without considering the
differences in measurement and sample. As stated previously, the demographics of the
current sample were different than the sample used by Bavarian and colleagues. Further,
the type of analysis is not a perfect comparison; Bavarian and colleagues ran logistic
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regression analyses with the original BEACH-Q and ran SEM analyses with the updated
BEACH-Q. Thus, comparisons from the current analyses and the analyses originally run
with both versions of the BEACH-Q have possible confounding factors. Overall, the
BEACH-Q appears to be a valuable measure with multiple important constructs relating
to IUPS and other issues that may be important for college students. However, although
the BEACH-Q was not specifically created to be a brief screening measure and should
not be expected to perform as such, the measure would not work as a brief screening
measure.
Hypothesis 2
After determining the effectiveness of the BEACH-Q in predicting IUPS, the new
measure was then examined more closely in an attempt to create a brief but
comprehensive predictive measure of IUPS. Two separate types of short-form measures
were created: a data-driven short-form resulting solely from the results of an exploratory
factor analysis and a hand-picked short-form that better represented the constructs
commonly discussed in the literature. One of the main issues with items included in the
new measure was multicollinearity. A large proportion of the items included were
correlated highly (i.e., above 0.6), and thus were not necessary in the factor analysis.
Although using this method to delete items removed a large portion of the measure, this
method allowed the constructs to remain and have overlapping items removed, quickly
decreasing the number of items included. The final factor structure for the data-driven
short-form included many important constructs often cited in the literature, including
negative expectancies of prescription stimulants, ADHD symptomology, and perceived
availability of stimulant medication. Also, this short-form included items related to risk
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perception of IUPS (including legal and health risk of different IUPS behaviors), which
previous measures have not included in as much detail.
However, although the data-driven short-form had strong predictive value in a
brief measure, there were some constructs that went unrepresented, including other drug
use and impulsivity/sensation-seeking. Thus, an alternative short-form measure was
created to better represent constructs in the literature. This process began by identifying
relevant constructs (e.g., impulsive/sensation-seeking, risk perception, other drug use,
ADHD symptomology, etc.), and then reducing the number of items relating to those
constructs to create a short-form measure. Although the final iteration of the hand-picked
short-form also left out certain theoretically important constructs (e.g., ADHD
symptomology, risk perception), the final constructs included were retained because they
were the most predictive of IUPS.
Post-hoc Analyses
Limited reliability analyses were conducted based on availability of items and
constructs for such analyses. One indication of reliability is that there were modest
correlations across related constructs on the BEACH-Q and the new measure. One
explanation for the modest correlations is that the constructs were not more highly related
due to being composed of different types of items. For example, the BEACH-Q items
regarding inattention are highly related to paying attention in class or in academic
settings (e.g., paying attention in class, keeping assignments organized), whereas the new
measure items regarding inattention are broader in scope (e.g., remembering
appointments, finishing details of a project, keeping attention during repetitive work).
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Although these constructs likely overlap, the relationship between the two measurements
may not be as strong as if the items were closer in content.
Another challenge in determining reliability between the new measure and the
BEACH-Q was due to the difference in operationalization of key variables. For example,
even slightly different wording in questions regarding race/ethnicity or class standing
resulted in some participants choosing different responses for each item. This was also
present for the items asking about likelihood of IUPS during college. This item was
originally presented in the BEACH-Q, and then was adapted for the new measure to
match terminology used elsewhere in the project (e.g., asking about likelihood of “illicit
use of prescription stimulant medication” rather than likelihood of using “for nonmedical
purposes” or “without a prescription from a healthcare provider”). Although overall the
responses were consistent across questions and some difference in responding could be a
result of expected measurement error for an internet survey, it is also possible that
conceptualizing IUPS in different ways depending on the terminology could change the
way participants think about IUPS while answering questions.
Literature and Theory Discussion
Although the literature surrounding IUPS among college students is vast and
thorough, there have been few attempts to create measures relating specifically to IUPS.
A number of larger or national surveys (e.g., Monitoring the Future, College Life Study)
have included questions relating to IUPS, but the measurement of IUPS is not the main
use of those measures. Other measures have been created in relation to IUPS, but have
either been long and complex (i.e., the BEACH-Q) or have been lacking important details
relating to IUPS (i.e., the SSQ).
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The HBM has been used as a theoretical guide to measure many different health
behaviors, and would likely be helpful in framing IUPS. Specifically, the data-driven
short-form included a number of concepts that relate well with the HBM, including
knowledge of others’ use or consequences, expectations of IUPS, and risk perception of
IUPS. This may be particularly useful, as the important factor relating to HBM is the
perceived benefits of IUPS, rather than the actual benefits. These concepts may be useful
when analyzing the cost-benefit analysis that may be undertaken by college students
when deciding to engage in IUPS, in that the expectations of IUPS need to outweigh the
perceptions of risk. Further, this cost-benefit analysis includes a consideration of the
obstacles that stand in the way of engaging in IUPS. For most students, obstacles to
engaging in IUPS are limited or non-existent, given that stimulant medications are often
easily available on campus and IUPS is a relatively prevalent behavior among college
students.
Limitations
Although the BEACH-Q was used as the “gold standard” for this project, there
were a number of barriers preventing appropriate comparisons between the BEACH-Q
and these newly formed measures. First, although the BEACH-Q is a comprehensive,
theory-driven measure that has resulted in a number of publications, the specifics of how
to operationalize the constructs represented is unclear. As discussed previously, the
logistic regression analysis used to gather an R2 value for the BEACH-Q was completed
by creating a total subscale scores for the most relevant BEACH-Q constructs (with
certain constructs included in the logistic regression separately due to lack of additive
clarity). Although these variables were created to represent the constructs in Bavarian and
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colleagues’ research as closely as possible, there were certain subscales that were up to
interpretation of how to create or define. Further, the demographic makeup of the sample
from Bavarian’s research was considerably different than the current sample. This is to be
expected, as the research was conducted in different areas of the country and different
types of universities. However, this limits even further the ability to make appropriate
comparisons between the results found by Bavarian and the results from the current
study.
Both a strength and limitation of this project is the specificity of the measures
used to predict IUPS. By limiting the scope of the intended predicted variable (i.e.
predicting only IUPS), the measures created were able to be more concise and more
directed at predicting IUPS. This is likely helpful for using measures to predict IUPS in
other research projects or in applied settings (e.g., doctors’ offices, student health centers,
Greek organizations, etc.). However, the result of brief but predictive measures is also
that they may not predict other illicit behaviors, including other types of substance use,
other risky behaviors, or IUPS in different time frames.
Another limitation of this project is the lack of ability to run certain reliability and
validity analyses. Specifically, items were not included so that divergent validity could be
assessed. Further validation of these measures is needed, with specific focus on test-retest
reliability and divergent validity.
Lastly, this project was conducted during one semester, and is thus a crosssectional analysis of IUPS. This is a common limitation within the literature, and presents
difficulty with making claims of predictive ability. Future studies should attempt to study

52

IUPS in a prospective fashion, particularly if the goal is to determine the predictive
ability of a measure.
Future Directions and Recommendations
This project was intended to be a first step in the larger goal of creating a concise,
efficient measure to best predict IUPS in a college setting. Thus, much work is left to be
done with improving the psychometric properties of these measures and determining the
effectiveness of these measures on other populations.
Predictive Validity
One specific future direction is to further validate the short-form measures created
in this project. A first step in continuing validation efforts could be running a
confirmatory factor analysis of the data-driven short-form on a new sample of
undergraduate students. Determining predictive validity could also be accomplished by
using the created measures in a prospective study of IUPS by college students. Although
the logistic regression analyses used in this project allow for participants to be classified
into users versus non-users, the classification rates are using cross-sectional data. It
would likely be more beneficial to see how well these constructs predict IUPS at a later
time. This information would assist in creating intervention programs for universities in
an attempt to reduce the prevalence of IUPS on college campuses. For example, if health
risk perception was shown to be particularly predictive of future IUPS, universities could
require incoming students to complete a psychoeducational program to increase
perceptions of health risk related to IUPS. A prospective study could also include
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analyses for test-retest reliability, to determine which constructs are stable over time and
which constructs may shift or need to be reassessed.
Divergent Validity
Another needed future direction is a project to help determine the divergent
validity of the short-form measures created in this project. Although convergent validity
was assessed in this project, it was not possible to assess divergent validity with the
measures used in this study. Further projects using either of the short-form measures
should be also used to confirm that the measures have adequate divergent validity. This
was not possible in this project, due to all of the constructs measured being theoretically
related to IUPS in some way. Thus, the next project should include other theoretically
unrelated constructs (e.g., psychosis, depression).
Other Uses for Short-Form Measures
Another possible future direction could be developing a measure to predict
specific IUPS behaviors (i.e., misuse, consumption, and diversion), rather than lifetime
IUPS. The short-form measures created in the current project were created to specifically
predict IUPS overall. However, there may be benefits to being able to accurately predict
specific IUPS behaviors. For example, determining risk of diverting medication may be
beneficial for medical doctors or university health centers. This may be particularly
helpful in determining what type or amount of psychoeducation to provide students
receiving stimulant medications, or could even help guide policy for how often students
need to have a check-in with their physician. Further, as discussed previously, identifying
specific risk factors for specific groups or overall could be beneficial in creating
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psychoeducational programs for college students. For example, incoming college
students could be asked to complete certain psychoeducational modules based on how
they respond to a screener for IUPS risk.
Face Validity and Measurement of IUPS
Developing a screening measure for substance use risk behavior to use in settings
where respondents may feel pressure to underreport their use would require eliminating
items that ask about behaviors people might be unwilling to answer in an honest manner
if they thought it might have negative ramifications. For example, if a patient completed
this measure in a physician’s waiting room, the patient may not want to reveal that they
have a history of sharing stimulant medication out of fear the physician may not renew or
initiate a prescription. One future direction of this line of research is determining the best
way to measure IUPS without face validity to prevent underreporting or skewed reporting
of rates of IUPS. Although college students generally perceive IUPS as not socially or
legally risky, and are typically open and honest when reporting these behaviors, there
could be other situations in which college students would not feel as comfortable
disclosing accurate information regarding their previous IUPS behaviors. For example,
students affiliated with an athletics team or a Greek organization may hesitate to report
previous IUPS behaviors if they are concerned with that information being disclosed to
those affiliations or if they are concerned that endorsing IUPS would reflect poorly on
their affiliation. This particular concern is the primary motivation for creating a measure
of IUPS that is not face valid to attempt to gain more information about predictors and
correlates of IUPS. The short-form measures created in this project were useful at
classifying participants into users versus non-users and explained a great amount of
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variance of IUPS; however, the items included on the measures were clearly related to
IUPS (e.g., risk perception of IUPS, perception of ease of access, use of other drugs). If
there were a measure that could predict IUPS with items that would be less likely to
receive false or underreported responses, it is possible that researchers could learn more
about IUPS in select groups of individuals (e.g., athletes).
IUPS at Different Universities
One important aspect of measuring IUPS is the effect of demographic variables
on prevalence of IUPS. A direct comparison to Bavarian and colleagues’ previous results
was impossible to make for a number of reasons, one of which being that the
demographic makeup of their sample was drastically different from the sample used in
this project. A future direction in this field, as well as in the validation of these short-form
measures, could be recruiting samples from multiple universities across the country.
Previous literature has shown effects of demographic variables on IUPS (e.g.,
race/ethnicity, Greek affiliation), and different areas of the country will likely have
different demographics broken down in their sample. It would be beneficial to confirm
the results of this project on other samples to determine if these short-form measures
would be beneficial for general use, or if there are other factors that need to be
considered.
IUPS Among Children and Adolescents
This project focused solely on predicting IUPS among college students. However,
college students sometimes report engaging in IUPS before coming to college. It may be
that intervention and prevention programs need to begin much earlier than when
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individuals are first entering college. It is possible, however, that adolescents have
different motivations for use and may have different risk factors for engaging in IUPS.
Thus, the short-form measures developed in this project may not be appropriate for
predicting risk of IUPS in middle school or high school students. A future project could
be to determine if modifications of these short-form measures would be useful with
younger populations.
Summary
This manuscript describes the initial development of two short-form measures for
IUPS. Two approaches were implemented, resulting in a data-driven short-form measure
and a hand-picked short-form measure. Both of these short-form measures were shown to
explain variance of lifetime IUPS and have accuracy in classifying participants into users
and non-users. Although they explained less variance of IUPS compared to the complete
BEACH-Q, each short-form measure was significantly shorter than the 100-item
BEACH-Q and may result in more practical utility. Further development of these shortform measures would benefit from being influenced or guided by the Health Belief
Model, which helps to include attitudes relating to IUPS and perceptions of risks and
benefits of IUPS. It is anticipated that further development will provide better
opportunities for IUPS to be better assessed in clinical and educational settings.
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BQ_1-9 For this first set of questions, think about your time as a college student, and rate how much you
agree or disagree with the following statements.
Strongly
disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly agree
(5)

It is difficult for
me to pay
attention during
class (1)

m

m

m

m

m

I often feel
restless (2)

m

m

m

m

m

It is difficult for
my to
concentrate on
my academic
work (3)

m

m

m

m

m

I am an
impulsive
person (4)

m

m

m

m

m

I have difficulty
keeping track
of my different
school
assignments (5)

m

m

m

m

m

I rarely plan
ahead (6)

m

m

m

m

m

I like "wild"
parties (7)

m

m

m

m

m

I enjoy getting
into situations
where I do not
know how
things will turn
out (8)

m

m

m

m

m

I prefer friends
who are
unpredictable
(9)

m

m

m

m

m
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BQ_10-12 During your time in college, how often have you:
None of the
time (1)

A little of the
time (2)

Some of the
time (3)

Most of the
time (4)

All of the time
(5)

Attended class
(1)

m

m

m

m

m

Read assigned
course readings
(2)

m

m

m

m

m

Worked on
course
assignments
(e.g., papers,
projects, etc.)
(3)

m

m

m

m

m

BQ_13-18 During your time in college, how often have you felt:
None of the
time (1)

A little of the
time (2)

Some of the
time (3)

Most of the
time (4)

All of the time
(5)

Worried about
your academic
performance (1)

m

m

m

m

m

Helpless about
your academic
performance (2)

m

m

m

m

m

Stressed about
your academic
performance (3)

m

m

m

m

m

Sad or blue (4)

m

m

m

m

m

Anxious (5)

m

m

m

m

m

Worried (6)

m

m

m

m

m
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BQ_19-22 Please rate how much you agree or disagree with the following statements:
Strongly
disagree (1)

Disagree (2)

Neutral (3)

Strongly agree
(5)

Agree (4)

Courses at this
university are
academically
demanding
(e.g., there is a
heavy
workload,
instructors
expect a lot
from students)
(1)

m

m

m

m

m

Students at this
university
compete with
each other for
the best grades
(2)

m

m

m

m

m

Professors at
this university
pay the most
attention to
students that
perform the
best in their
classes (3)

m

m

m

m

m

Receiving
praise for my
academic
performance
from my
professors is
important to me
(4)

m

m

m

m

m

BQ_23-24 .
No (1)

Yes (2)

Has a health care professional
EVER diagnosed you with
Attention Deficit Hyperactivity
Disorder or Attention Deficit
Disorder (ADHD/ADD)? (1)

m

m

Have you EVER had a
prescription for prescription
stimulants? (2)

m

m

71

BQ_25-27 During your time in college, how many times per academic term have you:

Never
(1)

Less
than
once (2)

1-2
times
(3)

3-5
times
(4)

6-9
times
(5)

10-19
times
(6)

20-39
times
(7)

40 or
more
times
(8)

Been
approached
for
prescription
stimulants?
(1)

m

m

m

m

m

m

m

m

Shared
prescription
stimulants
for free (2)

m

m

m

m

m

m

m

m

Shared
prescription
stimulants
for money
(3)

m

m

m

m

m

m

m

m
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BQ_28-31 For the following items, select the response that is currently most true for you.
Not at all
confident (1)

Somewhat
confident (2)

Moderately
confident (3)

Very
confident (4)

Completely
confident (5)

If a health care
provider
prescribed you
medical
stimulants, how
confident are
you that you
would not use
more than was
prescribed to
you? (1)

m

m

m

m

m

If someone
(e.g., friend,
family member,
acquaintance)
offered you
prescription
stimulants, how
confident are
you that you
would refuse
the offer? (2)

m

m

m

m

m

If you knew
someone (e.g.,
friend, family
member,
acquaintance)
who you could
get prescription
stimulants
from, how
confident are
you that you
would not ask
him/her for the
drug? (3)

m

m

m

m

m

If you had a lot
of school work
to do in a short
amount of time,
how confident
are you that
you would not
misuse
prescription
stimulant to
help you finish
your work? (4)

m

m

m

m

m
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BQ_32-34 How would the following people react if they discovered you engaged in prescription stimulant
misuse during college?
Very
negatively (1)

Negatively (2)

Neutrally (3)

Positively (4)

Very
positively (5)

Friends (1)

m

m

m

m

m

Family (2)

m

m

m

m

m

Campus
Faculty and
Staff (for
example,
instructors and
advisors) (3)

m

m

m

m

m

BQ_35-37 How many of the following people have ever suggested you engage in prescription stimulant
misuse during college?
None (1)

A few (2)

Some (3)

Most (4)

All (5)

Friends (1)

m

m

m

m

m

Family (2)

m

m

m

m

m

Campus
Faculty and
Staff (for
example,
instructors and
advisors) (3)

m

m

m

m

m
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BQ_38-40 What proportion of students at this university do you believe have ever used prescription
stimulants:
0% (1)

1-10% (2)

11-25% (3)

26-50% (4)

51-75% (5)

More than
75% (6)

Without a
prescription
from a health
care
provider? (1)

m

m

m

m

m

m

For
nonmedical
purposes
(i.e., to help
with
studying, to
stay awake,
to get high)?
(2)

m

m

m

m

m

m

In excess of
what was
prescribed to
them? (3)

m

m

m

m

m

m
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BQ_41-43 What proportion of your close friends (i.e., friends that you associate the most frequently) do
you believe have ever used prescription stimulants:
0% (1)

1-10% (2)

11-25% (3)

26-50% (4)

51-75% (5)

More than
75% (6)

Without a
prescription
from a health
care
provider? (1)

m

m

m

m

m

m

For
nonmedical
purposes
(i.e., to help
with
studying, to
stay awake,
to get high)?
(2)

m

m

m

m

m

m

In excess of
what was
prescribed to
them? (3)

m

m

m

m

m

m
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BQ_44-46 Please rate how much you agree or disagree with the following statements:
Strongly
disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly agree
(5)

I think it is
okay for
college
students to use
prescription
stimulants
without a
prescription
from a health
care provider
(1)

m

m

m

m

m

I think it is
okay for
college
students to use
prescription
stimulants for
nonmedical
purposes (i.e.,
to help with
studying, to
stay awake, to
get high) (2)

m

m

m

m

m

I think it is
okay for
college
students to use
prescription
stimulants in
excess of what
has been
prescribed (3)

m

m

m

m

m

BQ_47 If you said "Strongly disagree" or "Disagree" to the previous questions, why do you feel this way?
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BQ_48-49 During your time in college, how frequently have you:
None of the
time (1)

A little of the
time (2)

Some of the
time (3)

Most of the
time (4)

All of the time
(5)

Seen
advertisements
for prescription
drugs on
television (1)

m

m

m

m

m

Seen
advertisements
for prescription
drugs in print
media (e.g.,
Internet,
Magazines,
Newspaper) (2)

m

m

m

m

m

BQ_50-51 Please rate how much you currently agree or disagree with the following statements:
Strongly
disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly agree
(5)

College is a
time when
students
experiment
with different
drugs (e.g.,
alcohol,
marijuana,
prescription
drugs, etc.) (1)

m

m

m

m

m

It is easy to find
a health care
provider (i.e.,
nurse or doctor)
to write a
prescription for
a prescription
stimulant, even
if a student
does not really
have
ADD/ADHD
(2)

m

m

m

m

m
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BQ_52-63 Please indicate how often you would expect each item below to occur to you if you were to
engage in prescription stimulant misuse during college.
None of the
time (1)

A little of the
time (2)

Some of the
time (3)

Most of the
time (4)

All of the
time (5)

I would get better
grades (1)

m

m

m

m

m

I would find
studying more
enjoyable (2)

m

m

m

m

m

I would be able
to stay awake (3)

m

m

m

m

m

I would be able
to
concentrate/focus
better (4)

m

m

m

m

m

I would lose
weight (5)

m

m

m

m

m

I would be able
to party longer
(6)

m

m

m

m

m

I would feel
anxious (7)

m

m

m

m

m

I would feel
dizzy/lightheaded
(8)

m

m

m

m

m

My heart would
race (9)

m

m

m

m

m

I would not be
able to sleep (10)

m

m

m

m

m

I would get in
trouble (11)

m

m

m

m

m

I would get
headaches (12)

m

m

m

m

m
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BQ_64-66 How likely is it that, during your time in college, you will use prescription stimulants...
Definitely
won't (1)

Probably
won't (2)

Not sure (3)

Probably will
(4)

Definitely will
(5)

Without a
prescription
from a health
care provider?
(1)

m

m

m

m

m

For nonmedical
purposes (i.e.,
to help with
studying, to
stay awake, to
get high)? (2)

m

m

m

m

m

In excess of
what may be
prescribed to
you? (3)

m

m

m

m

m

BQ_67-69 During your time in college, have you ever used prescription stimulants...
No (1)

Yes (2)

Without a prescription from a
health care provider? (1)

m

m

For nonmedical purposes (i.e., to
help with studying, to stay
awake, to get high)? (2)

m

m

In excess of what was prescribed
to you? (3)

m

m

BQ_70 During your time in college, on how many occasions per academic term have you participated in
prescription stimulant misuse?
m
m
m
m
m
m
m
m

Never (1)
Less than once (2)
1-2 occasions (3)
3-5 occasions (4)
6-9 occasions (5)
10-19 occasions (6)
20-39 occasions (7)
40 or more occasions (8)
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BQ_71 When was the first time you engaged in prescription stimulant misuse?
m
m
m
m
m

Elementary school (1)
Middle school (2)
High school (3)
College (4)
I have never engaged in prescription stimulant misuse (5)

BQ_72 IF you have EVER participated in prescription stimulant misuse, how do you take the drug? (Select
"Yes" to all that are true for you and "No" to all that are NOT true for you)
Yes (1)

No (2)

Swallow (mouth) (1)

q

q

Snort (nose) (2)

q

q

Inject (veins) (3)

q

q

Smoke (4)

q

q

Other (please specify) (5)

q

q

NOT APPLICABLE (6)

q

q

BQ_73 IF you have EVER participated in prescription stimulant misuse, how much money have you spent
per pill? (Select "Yes" to all that are true for you and "No" to all that are NOT true for you)
Yes (1)

No (2)

No charge (1)

q

q

$1-$5 (2)

q

q

$6-$10 (3)

q

q

More than $10 (4)

q

q

NOT APPLICABLE (5)

q

q
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BQ_74 IF you have EVER participated in prescription stimulant misuse, who provided you with the drug?
(Select "Yes" to all that are true for you and "No" to all that are NOT true for you)
Yes (1)

No (2)

Myself (Because I have a
prescription) (1)

q

q

Friend (2)

q

q

Family member (3)

q

q

Acquaintance (For example, a
friend of a friend, or a classmate
that is not a friend) (4)

q

q

Internet (5)

q

q

Other (please specify) (6)

q

q

NOT APPLICABLE (7)

q

q

BQ_75 IF you have EVER participated in prescription stimulant misuse, why did you do so? (Select "Yes"
to all that are true for you and "No" to all that are NOT true for you)
Yes (1)

No (2)

To improve focus (1)

q

q

To make studying more
enjoyable (2)

q

q

To stay awake (3)

q

q

To improve concentration (4)

q

q

To lose weight (5)

q

q

To party longer (6)

q

q

To experiment (7)

q

q

Other (please specify) (8)

q

q

NOT APPLICABLE (9)

q

q
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BQ_76 IF you have EVER participated in prescription stimulant misuse, how often did your use produce
the outcome(s) you desired?
m
m
m
m
m
m

None of the time (1)
A little of the time (2)
Some of the time (3)
Most of the time (4)
All of the time (5)
NOT APPLICABLE (6)

BQ_77-81 During your time in college, on how many occasions per academic term have you used:

Never
(1)

Less
than
once (2)

1-2
times
(3)

3-5
times
(4)

6-9
times
(5)

10-19
times
(6)

20-39
times
(7)

40 or
more
times
(8)

Tobacco
(i.e.,
cigarettes,
cigars,
hookah) (1)

m

m

m

m

m

m

m

m

Alcohol
(i.e., beer,
wine,
liquor) (2)

m

m

m

m

m

m

m

m

Marijuana
(3)

m

m

m

m

m

m

m

m

Cocaine (4)

m

m

m

m

m

m

m

m

Prescription
pain killers
(e.g.,
OxyContin,
Vicodin,
Codeine)
without
prescription,
for
nonmedical
reasons,
and/or in
excess of
what was
prescribed
(5)

m

m

m

m

m

m

m

m
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BQ_82-85 Finally, please tell us about yourself. During your time in college, how often have you:
None of the
time (1)

A little of the
time (2)

Some of the
time (3)

Most of the
time (4)

All of the time
(5)

Attended a
place of
worship (e.g., a
church,
mosque, or
synagogue)? (1)

m

m

m

m

m

Relied on
religious
teachings when
you have a
problem? (2)

m

m

m

m

m

Turned to
prayer or
meditation
when you faced
a personal
problem? (3)

m

m

m

m

m

Relied on your
religious beliefs
as a guide for
day-to-day
living? (4)

m

m

m

m

m

BQ_86 To what extent do you agree with the following statement: In general, I want to do what persons
who are important to me think I should do.
m
m
m
m
m
m

Strongly disagree (1)
Disagree (2)
Neutral (3)
Agree (4)
Strongly agree (5)
Not applicable (6)

BQ_87 How old are you (in years)?

BQ_88 How many hours a week do you work, volunteer, and/or intern?
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BQ_89 How many credits are you enrolled in this academic term?

BQ_90 What is your gender identity? (e.g., Female, Male, F:M Transgender, M:F Transgender, Other, Not
sure)

BQ_91 What is your year in school?
m
m
m
m
m
m
m
m

1st year undergraduate (1)
2nd year undergraduate (2)
3rd year undergraduate (3)
4th year undergraduate (4)
5th year or more undergraduate (5)
Post baccalaureate student (6)
Graduate student (7)
Other (please specify) (8) ____________________

BQ_92 What is your approximate cumulative college grade/grade point average?
m
m
m
m
m
m

I do not yet have a GPA (1)
F (0.00-0.49) (2)
D (0.50-1.49) (3)
C (1.50-2.49) (4)
B (2.50-3.49) (5)
A (3.50-4.00+) (6)

BQ_93 How do you usually describe yourself? (Please select the ONE group that you MOST identify as)
m
m
m
m
m
m
m
m

White, non Hispanic (includes Middle Eastern) (1)
Black, non Hispanic (2)
Hispanic or Latino/a (3)
Asian or Pacific Islander (4)
South Asian (5)
American Indian, Alaskan Native, or Native Hawaiian (6)
Biracial or multiracial (7)
Other (8)

BQ_94 Are you an international student?
m No (1)
m Yes (2)
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BQ_95 Where do you currently live?
m
m
m
m

Campus housing (i.e., residence hall) (1)
Fraternity or sorority house (2)
Parent/guardian's home (3)
Other off-campus housing (e.g., an apartment or studio) (4)

BQ_96 Are you a member of a social fraternity or sorority? (e.g., National Interfraternity Council,
Multicultural Council)
m No (1)
m Yes (2)
BQ_97 Are you a member of an intercollegiate or club college sports team?
m No (1)
m Yes (2)
BQ_98 Where do you go most often for health care?
m
m
m
m
m
m

Campus health services (1)
Pharmacy (2)
Family doctor (3)
Hospital (4)
Other (please specify) (5) ____________________
I do not receive health care (6)

BQ_99 How would you describe the current state of your finances?
m
m
m
m
m

Poor (1)
Fair (2)
Good (3)
Very good (4)
Excellent (5)

BQ_100 How would you describe your general health?
m
m
m
m
m

Poor (1)
Fair (2)
Good (3)
Very good (4)
Excellent (5)
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Q101 Have you ever been diagnosed with ADHD (Attention-Deficit/Hyperactivity Disorder) or ADD
(Attention Deficit Disorder)?
m Yes (1)
m No (2)
Q102 Do you currently have a diagnosis for ADHD (Attention-Deficit/Hyperactivity Disorder) or ADD
(Attention Deficit Disorder)?
m Yes (1)
m No (2)
Q103 How dissatisfied are you with the amount of time that you need to spend studying to be successful?
m
m
m
m

I'm satisfied with the amount of time (1)
I'm slightly dissatisfied with the amount of time (2)
I'm dissatisfied with the amount of time (3)
I'm very dissatisfied with the amount of time (4)

Q104 How dissatisfied are you with your current GPA?
m
m
m
m

I'm satisfied with my current GPA (1)
I'm slightly dissatisfied with my current GPA (2)
I'm dissatisfied with my current GPA (3)
I'm very dissatisfied with my current GPA (4)

Q105 Do you currently have a prescription for stimulant medication?
m Yes, I have a current prescription for stimulant medication (e.g., Adderall, Concerta, Ritalin, Vyvanse,
etc.) (1)
m No, I have a current prescription for a non-stimulant medication (e.g., Strattera, Effexor, etc.) (2)
m Yes, but I do not know what it is (3)
m No (4)
Q106 Have you had a prescription in the past but no longer have one?
m Yes (1)
m No (2)
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Answer If Do you currently have a prescription for stimulant medication? Yes, I have a current prescription
for stimulant medication (e.g., Adderall, Concerta, Ritalin, Vyvanse, etc.) Is Selected Or Have you had a
prescription in the past but no longer have one? Yes Is Selected
Q107 Have you ever taken a larger dose than prescribed?
m Yes (1)
m No (2)
Answer If Have you ever taken a larger dose than prescribed? Yes Is Selected
Q108 When did you first try taking a larger dose than prescribed?
m
m
m
m

In college (1)
In high school (9th to 12th grade) (2)
In grades 7th to 8th (3)
Before 7th grade (4)

Answer If Have you ever taken a larger dose than prescribed? Yes Is Selected
PLDC Have you taken a larger dose than prescribed during college?
m Yes (1)
m No (2)
Answer If Have you ever taken a larger dose than prescribed? Yes Is Selected
Q109 Have you taken a larger dose than prescribed in the past year?
m Yes (1)
m No (2)
Answer If Have you taken a larger dose than prescribed in the past year? Yes Is Selected
Q110 Have you taken a larger dose than prescribed in the past month?
m Yes (1)
m No (2)
Answer If Do you currently have a prescription for stimulant medication? Yes, I have a current prescription
for stimulant medication (e.g., Adderall, Concerta, Ritalin, Vyvanse, etc.) Is Selected Or Have you had a
prescription in the past but no longer have one? Yes Is Selected
Q111 Have you ever taken a more frequent dosage than prescribed?
m Yes (1)
m No (2)
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Answer If Have you taken a more frequent dosage than prescribed in the past year? Yes Is Selected
Q112 When did you first try taking a more frequent dosage than prescribed?
m
m
m
m

In college (1)
In high school (9th to 12th grade) (2)
In grades 7th to 8th (3)
Before 7th grade (4)

Answer If Have you ever taken a more frequent dosage than prescribed? Yes Is Selected
PMFC Have you taken a more frequent dosage than prescribed during college?
m Yes (1)
m No (2)
Answer If Have you taken a more frequent dosage than prescribed in the past year? Yes Is Selected
Q113 Have you taken a more frequent dosage than prescribed in the past year?
m Yes (1)
m No (2)
Answer If Have you taken a more frequent dosage than prescribed in the past year? Yes Is Selected
Q114 Have you taken a more frequent dosage than prescribed in the past month?
m Yes (1)
m No (2)
Q115 Have you ever consumed someone else's prescription stimulant medication (whether you had a
prescription of your own or not)?
m Yes (1)
m No (2)
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Answer If Have you ever consumed someone else's prescription stimulant medication (whether you had a
prescr... Yes Is Selected
Q116 How many times have you consumed someone else's prescription stimulant medication (whether you
had a prescription of your own or not) during your lifetime?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Answer If Have you ever consumed someone else's prescription stimulant medication (whether you had a
prescr... Yes Is Selected
Q117 When did you first consume someone else's prescription stimulant medication (whether you had a
prescription of your own or not)?
m
m
m
m

In college (1)
In high school (9th to 12th grade) (2)
In grades 7th to 8th (3)
Before 7th grade (4)

Answer If Have you ever consumed someone else's prescription stimulant medication (whether you had a
prescr... Yes Is Selected
PConC Have you consumed someone else's prescription stimulant medication (whether you had a
prescription of your own or not) during college?
m Yes (1)
m No (2)
Answer If Have you ever consumed someone else's prescription stimulant medication (whether you had a
prescr... Yes Is Selected
Q118 Have you consumed someone else's prescription stimulant medication (whether you had a
prescription of your own or not) in the past year?
m Yes (1)
m No (2)
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Answer If Have you consumed someone else's prescription stimulant medication (whether you had a
prescriptio... Yes Is Selected
Q119 How frequently have you consumed someone else's prescription stimulant medication (whether you
had a prescription of your own or not) in the past year?
m
m
m
m
m

1 time (1)
2-3 times (2)
4-5 times (3)
6-7 times (4)
More than 7 times (5)

Answer If Have you consumed someone else's prescription stimulant medication (whether you had a
prescriptio... Yes Is Selected
Q120 Have you consumed someone else's prescription stimulant medication (whether you had a
prescription of your own or not) in the past month?
m Yes (1)
m No (2)
Answer If Have you consumed someone else's prescription stimulant medication (whether you had a
prescriptio... Yes Is Selected
Q121 How frequently have you consumed someone else's prescription stimulant medication (whether you
had a prescription of your own or not) in the past month?
m
m
m
m
m

1 time (1)
2-3 times (2)
4-5 times (3)
6-7 times (4)
More than 7 times (5)

Q122 Have you ever sold prescription stimulant medication to someone?
m Yes (1)
m No (2)
Answer If Have you ever sold prescription stimulant medication to someone? Yes Is Selected
Q123 When did you first sell prescription stimulant medication to someone?
m
m
m
m

In college (1)
In high school (9th to 12th grade) (2)
In grades 7th to 8th (3)
Before 7th grade (4)
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Answer If Have you ever sold prescription stimulant medication to someone? Yes Is Selected
Q124 How frequently have you sold prescription stimulant medication to someone in your lifetime?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Answer If Have you ever sold prescription stimulant medication to someone? Yes Is Selected
PSellC Have you sold prescription stimulant medication to someone during college?
m Yes (1)
m No (2)
Answer If Have you ever sold prescription stimulant medication to someone? Yes Is Selected
Q125 Have you sold prescription stimulant medication to someone in the past year?
m Yes (1)
m No (2)
Answer If Have you sold prescription stimulant medication to someone in the past year? Yes Is Selected
Q126 How frequently have you sold prescription stimulant medication to someone in the past year?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Answer If Have you sold prescription stimulant medication to someone in the past year? Yes Is Selected
Q127 Have you sold prescription stimulant medication to someone in the past month?
m Yes (1)
m No (2)
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Answer If Have you sold prescription stimulant medication to someone in the past month? Yes Is Selected
Q128 How frequently have you sold prescription stimulant medication to someone in the past month?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Q129 Have you ever shared or given away prescription stimulant medication?
m Yes (1)
m No (2)
Answer If Have you ever shared or given away prescription stimulant medication? Yes Is Selected
Q130 When did you first share or give away prescription stimulant medication?
m
m
m
m

In college (1)
In high school (9th to 12th grade) (2)
In grades 7th to 8th (3)
Before 7th grade (4)

Answer If Have you ever shared or given away prescription stimulant medication? Yes Is Selected
Q131 How frequently have you shared or given away prescription stimulant medication in your lifetime?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Answer If Have you ever shared or given away prescription stimulant medication? Yes Is Selected
PShareC Have you shared or given away prescription stimulant medication during college?
m Yes (1)
m No (2)
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Answer If Have you ever shared or given away prescription stimulant medication? Yes Is Selected
Q132 Have you shared or given away prescription stimulant medication in the past year?
m Yes (1)
m No (2)
Answer If Have you shared or given away prescription stimulant medication in the past year? Yes Is
Selected
Q133 How frequently have you shared or given away prescription stimulant medication in the past year?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Answer If Have you shared or given away prescription stimulant medication in the past year? Yes Is
Selected
Q134 Have you shared or given away prescription stimulant medication in the past month?
m Yes (1)
m No (2)
Answer If Have you shared or given away prescription stimulant medication in the past month? Yes Is
Selected
Q135 How frequently have you shared or given away prescription stimulant medication in the past month?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Q136 Have you ever traded prescription stimulant medication for something else or traded something for
prescription stimulant medication?
m Yes (1)
m No (2)
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Answer If Have you ever traded prescription stimulant medication for something else? Yes Is Selected
Q137 When did you first trade prescription stimulant medication for something else or traded something
else for prescription stimulant medication?
m
m
m
m

In college (1)
In high school (9th to 12th grade) (2)
In grades 7th to 8th (3)
Before 7th grade (4)

Answer If Have you ever traded prescription stimulant medication for something else? Yes Is Selected
Q138 How frequently have you traded prescription stimulant medication for something else or traded
something for prescription stimulant medication in your lifetime?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Answer If Have you ever traded prescription stimulant medication for something else or traded something
for... Yes Is Selected
PTradeC Have you traded prescription stimulant medication for something else or traded something for
prescription stimulant medication during college?
m Yes (1)
m No (2)
Answer If Have you ever traded prescription stimulant medication for something else? Yes Is Selected
Q139 Have you traded prescription stimulant medication for something else or traded something for
prescription stimulant medication in the past year?
m Yes (1)
m No (2)
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Answer If Have you traded prescription stimulant medication for something else in the past year? Yes Is
Selected
Q140 How frequently have you traded prescription stimulant medication for something else or traded
something for prescription stimulant medication in the past year?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Answer If Have you traded prescription stimulant medication for something else in the past year? Yes Is
Selected
Q141 Have you traded prescription stimulant medication for something else or traded something for
prescription stimulant medication in the past month?
m Yes (1)
m No (2)
Answer If Have you traded prescription stimulant medication for something else in the past month? Yes Is
Selected
Q142 How frequently have you traded prescription stimulant medication for something else or traded
something for prescription stimulant medication in the past month?
m
m
m
m
m
m
m

None (1)
1-2 times (2)
3-5 times (3)
6-9 times (4)
10-19 times (5)
20-39 times (6)
40 or more times (7)

Q143 How much of a legal risk is posed by misusing one's own prescription stimulant medication (i.e.,
taking a larger or more frequent dose)?
m
m
m
m

Not risky at all (1)
Slightly risky (2)
Risky (3)
Very risky (4)
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Q144 How much of a health risk is posed by misusing one's own prescription stimulant medication (i.e.,
taking a larger or more frequent dose)?
m
m
m
m

Not risky at all (1)
Slightly risky (2)
Risky (3)
Very risky (4)

Q145 How much of a social risk is posed by misusing one's own prescription stimulant medication (i.e.,
taking a larger or more frequent dose)?
m
m
m
m

Not risky at all (1)
Slightly risky (2)
Risky (3)
Very risky (4)

Q146 How much of a legal risk is posed by consuming someone else's prescription stimulant medication?
m
m
m
m

Not risky at all (1)
Slightly risky (2)
Risky (3)
Very risky (4)

Q147 How much of a health risk is posed by consuming someone else's prescription stimulant medication?
m
m
m
m

Not risky at all (1)
Slightly risky (2)
Risky (3)
Very risky (4)

Q148 How much of a social risk is posed by consuming someone else's prescription stimulant medication?
m
m
m
m

Not risky at all (1)
Slightly risky (2)
Risky (3)
Very risky (4)
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Q149 How much of a legal risk is posed by diverting (i.e., sharing, selling, or trading) prescription
stimulant medication?
m
m
m
m

Not risky at all (1)
Slightly risky (2)
Risky (3)
Very risky (4)

Q150 How much of a health risk is posed by diverting (i.e., sharing, selling, or trading) prescription
stimulant medication?
m
m
m
m

Not risky at all (1)
Slightly risky (2)
Risky (3)
Very risky (4)

Q151 How much of a social risk is posed by diverting (i.e., sharing, selling, or trading) prescription
stimulant medication?
m
m
m
m

Not risky at all (1)
Slightly risky (2)
Risky (3)
Very risky (4)
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Q152-163 Please respond "Yes" or "No" to each of the following questions regarding illicit use of
prescription stimulant medication.
Q152-162

Yes (1)

No (2)

Do you know someone
personally how has gotten into
legal trouble due to illicit use?
(1)

m

m

Have you heard of someone at
your school who has gotten into
legal trouble due to illicit use?
(2)

m

m

Have your heard of someone at
another school (not the school
you attend) who has gotten into
legal trouble due to illicit use?
(3)

m

m

Do you know someone
personally who has gotten into
academic trouble due to illicit
use? (4)

m

m

Have you heard of someone at
your school who has gotten into
academic trouble due to illicit
use? (5)

m

m

Have you heard of someone at
another school (not the school
you attend) who has gotten into
academic trouble due to illicit
use? (6)

m

m

Do you know someone
personally who has experienced a
negative health event due to
illicit use? (7)

m

m

Have you heard of someone at
your school who has experienced
a negative health event due to
illicit use? (8)

m

m
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Q152-162 (continued)

Yes (1)

No (2)

Have you heard of someone at
another school (not the school
you attend) who has experienced
a negative health event due to
illicit use? (9)

m

m

Do you know someone
personally who has experienced
social rejection due to illicit use?
(10)

m

m

Have you heard of someone at
your school who has experienced
social rejection due to illicit use?
(11)

m

m

Have you heard of someone at
another school (not the school
you attend) who has experienced
social rejection due to illicit use?
(12)

m

m

Answer If Have you ever consumed someone else's prescription stimulant medication (whether you had a
prescr... Yes Is Selected
Q164-167 Have you ever stopped or reduced illicit use of stimulant medication because of...
Yes (1)

No (2)

Have never engaged in
illicit use (3)

Possible legal trouble?
(1)

m

m

m

Possible academic
trouble? (2)

m

m

m

Possible negative health
events? (3)

m

m

m

Possible social
rejection? (4)

m

m

m
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Q168-185
Q168-185

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Very often (5)

How often do
you have
trouble
wrapping up the
final details of a
project once the
challenging
parts have been
done? (1)

m

m

m

m

m

How often do
you have
difficulty
getting things in
order when you
have to do a
task that
requires
organization?
(2)

m

m

m

m

m

How often do
you have
problems
remembering
appointments or
obligations? (3)

m

m

m

m

m

When you have
a task that
requires a lot of
thought, how
often do you
avoid or delay
getting started?
(4)

m

m

m

m

m
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Q168-185
(continued)

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Very often (5)

How often do
you fidget or
squirm with
your hands or
feet when you
have to sit
down for a long
time? (5)

m

m

m

m

m

How often do
you feel overly
active and
compelled to do
things, like you
were driven by
a motor? (6)

m

m

m

m

m

How often do
you make
careless
mistakes when
you have to
work on a
boring or
difficult
project? (7)

m

m

m

m

m

How often do
you have
difficulty
keeping your
attention when
you are doing
boring or
repetitive work?
(8)

m

m

m

m

m

How often do
you have
difficulty
concentrating
on what people
say to you, even
when they are
speaking to you
directly? (9)

m

m

m

m

m
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Q168-185
(continued)

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Very often (5)

How often do
you misplace or
have difficulty
finding things
at home or at
work? (10)

m

m

m

m

m

How often are
you distracted
by activity or
noise around
you? (11)

m

m

m

m

m

How often do
you leave your
seat in meetings
or other
situations in
which you are
expected to
remain seated?
(12)

m

m

m

m

m

How often do
you feel restless
or fidgety? (13)

m

m

m

m

m

How often do
you have
difficulty
unwinding and
relaxing when
you have time
to yourself?
(14)

m

m

m

m

m
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Q168-185
(continued)

Never (1)

Rarely (2)

Sometimes (3)

Often (4)

Very often (5)

How often do
you find
yourself talking
too much when
you are in
social
situations? (15)

m

m

m

m

m

When you're in
a conversation,
how often do
you find
yourself
finishing the
sentences of the
people you are
talking to,
before they can
finish them
themselves?
(16)

m

m

m

m

m

How often do
you have
difficulty
waiting your
turn in
situations when
turn taking is
required? (17)

m

m

m

m

m

How often do
you interrupt
others when
they are busy?
(18)

m

m

m

m

m

Q186 Have you ever tried energy drinks?
m Yes (1)
m No (2)
Answer If Have you ever tried energy drinks? Yes Is Selected
Q187 Have you tried or used energy drinks in the past year?
m Yes (1)
m No (2)
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Answer If Have you tried or used energy drinks in the past year? Yes Is Selected
Q188 Have you tried or used energy drinks in the past month?
m Yes (1)
m No (2)
Q189 Have you ever tried nicotine (e.g., cigarettes, chewing tobacco, vaping)?
m Yes (1)
m No (2)
Answer If Have you ever tried nicotine? Yes Is Selected
Q190 Have you tried or used nicotine (e.g., cigarettes, chewing tobacco, vaping) in the past year?
m Yes (1)
m No (2)
Answer If Have you tried or used nicotine in the past year? Yes Is Selected
Q191 Have you tried or used nicotine (e.g., cigarettes, chewing tobacco, vaping) in the past month?
m Yes (1)
m No (2)
Q192 Have you ever tried alcohol?
m Yes (1)
m No (2)
Answer If Have you ever tried alcohol? Yes Is Selected
Q193 Have you tried or used alcohol in the past year?
m Yes (1)
m No (2)
Answer If Have you tried or used alcohol in the past year? Yes Is Selected
Q194 Have you tried or used alcohol in the past month?
m Yes (1)
m No (2)
Q195 Have you ever tried marijuana?
m Yes (1)
m No (2)
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Answer If Have you ever tried marijuana? Yes Is Selected
Q196 Have you tried or used marijuana in the past year?
m Yes (1)
m No (2)
Answer If Have you tried or used marijuana in the past year? Yes Is Selected
Q197 Have you tried or used marijuana in the past month?
m Yes (1)
m No (2)
Q198 Have you ever tried cocaine?
m Yes (1)
m No (2)
Answer If Have you ever tried cocaine? Yes Is Selected
Q199 Have you tried or used cocaine in the past year?
m Yes (1)
m No (2)
Answer If Have you tried or used cocaine in the past year? Yes Is Selected
Q200 Have you tried or used cocaine in the past month?
m Yes (1)
m No (2)
Q201 Have you ever tried amphetamines (e.g., speed, uppers, bennies)?
m Yes (1)
m No (2)
Answer If Have you ever tried amphetamines? Yes Is Selected
Q202 Have you tried or used amphetamines (e.g., speed, uppers, bennies) in the past year?
m Yes (1)
m No (2)
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Answer If Have you tried or used amphetamines in the past year? Yes Is Selected
Q203 Have you tried or used amphetamines (e.g., speed, uppers, bennies) in the past month?
m Yes (1)
m No (2)
Q204 Have you ever tried hallucinogens (e.g., LSD, PCP, salvia, ketamine, mescaline (peyote); otherwise
known as acid, special K, angel dust, etc.)?
m Yes (1)
m No (2)
Answer If Have you ever tried hallucinogens (e.g., LSD, PCP, salvia, ketamine, mescaline (peyote);
otherwise known as acid, special K, angel dust, etc.)? Yes Is Selected
Q205 Have you tried hallucinogens (e.g., LSD, PCP, salvia, ketamine, mescaline (peyote); otherwise
known as acid, special K, angel dust, etc.) in the past year?
m Yes (1)
m No (2)
Answer If Have you tried hallucinogens (e.g., LSD, PCP, salvia, ketamine, mescaline (peyote); otherwise
known as acid, special K, angel dust, etc.) in the past year? Yes Is Selected
Q206 Have you tried hallucinogens (e.g., LSD, PCP, salvia, ketamine, mescaline (peyote); otherwise
known as acid, special K, angel dust, etc.) in the past month?
m Yes (1)
m No (2)
Q207 Have you ever tried prescription opiates (e.g., OxyContin, Percocet, Vicodin) without a prescription?
m Yes (1)
m No (2)
Answer If Have you ever tried prescription opiates? Yes Is Selected
Q208 Have you tried prescription opiates (e.g., OxyContin, Percocet, Vicodin) without a prescription in the
past year?
m Yes (1)
m No (2)
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Answer If Have you tried prescription opiates in the past year? Yes Is Selected
Q209 Have you tried prescription opiates (e.g., OxyContin, Percocet, Vicodin) without a prescription in the
past month?
m Yes (1)
m No (2)
Q210 Have you ever tried prescription sedatives (e.g., tranquilizers or depressants; including Xanax,
Valium, Ativan, Ambien, sleeping pills, yellow jackets) without a prescription?
m Yes (1)
m No (2)
Answer If Have you ever tried prescription sedatives (e.g., tranquilizers or depressants; including Xanax,
Valium, Ativan, Ambien, sleeping pills, yellow jackets) without a prescription? Yes Is Selected
Q211 Have you tried prescription sedatives (e.g., tranquilizers or depressants; including Xanax, Valium,
Ativan, Ambien, sleeping pills, yellow jackets) without a prescription in the past year?
m Yes (1)
m No (2)
Answer If Have you&nbsp;tried prescription sedatives (e.g., tranquilizers or depressants; including Xanax,
Valium, Ativan, Ambien, sleeping pills, yellow jackets) without a prescription in the past year? Yes Is
Selected
Q212 Have you tried prescription sedatives (e.g., tranquilizers or depressants; including Xanax, Valium,
Ativan, Ambien, sleeping pills, yellow jackets) without a prescription in the past month?
m Yes (1)
m No (2)

108

Q213-257 Indicate whether you would expect to experience each consequence as a result of using a
prescription stimulant medication.
Q213-257

Not at all (1)

Sometimes (2)

Very often or always
(3)

Distractions disappear
(1)

m

m

m

I absorb material the first
time through (2)

m

m

m

I feel very happy (3)

m

m

m

I can ignore distractions
more easily (4)

m

m

m

I can pay attention really
well (5)

m

m

m

I can study/work for
hours (6)

m

m

m

I can't hold still (7)

m

m

m

I can't sleep even if I
want to (8)

m

m

m

I enjoy parties more (9)

m

m

m

I don't end up
daydreaming (10)

m

m

m

I enjoy studying/working
a lot more (11)

m

m

m

I feel drained the next
day (12)

m

m

m

Conversing with others
is easier (13)

m

m

m
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Q213-257 (continued)

Not at all (1)

Sometimes (2)

Very often or always
(3)

I feel like I can't get
through the day without
it (14)

m

m

m

I feel like I'm cutting
corners to do well (15)

m

m

m

I feel sick to my stomach
(16)

m

m

m

I feel high (17)

m

m

m

I am friendlier (18)

m

m

m

I learn/work very
efficiently (19)

m

m

m

I need fewer breaks
when I study/work (20)

m

m

m

I worry that I'm addicted
to it (21)

m

m

m

I'm all amped up (22)

m

m

m

I feel more confident in
myself (23)

m

m

m

I've come to see it as a
crutch (24)

m

m

m

My ability to focus is
better (25)

m

m

m

My concentration is
excellent (26)

m

m

m

My focus is crystal clear
(27)

m

m

m

My head hurts (28)

m

m

m

I'm free to be myself and
do whatever I want to do
(29)

m

m

m

My mind doesn't wander
(30)

m

m

m
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Q213-257 (continued)

Not at all (1)

Sometimes (2)

Very often or always
(3)

My mind is razor sharp
(31)

m

m

m

My thoughts follow
more logically (32)

m

m

m

I feel more relaxed in
social situations (33)

m

m

m

My work seems more
interesting (34)

m

m

m

My heart races (35)

m

m

m

I can focus very well
(36)

m

m

m

I can't calm down (37)

m

m

m

I feel twitchy (38)

m

m

m

I feel as though
everything is right in the
world (39)

m

m

m

It's no trouble to sit still
(40)

m

m

m

My memory is better
(41)

m

m

m

I feel guilty for taking it
(42)

m

m

m

I get nervous and edgy
(43)

m

m

m

My thoughts stay on
track better (44)

m

m

m

I laugh more (45)

m

m

m
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Q258-266 Please answer the following questions.
Strongly
disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly agree
(5)

I know
students who I
can get
stimulants
from. (1)

m

m

m

m

m

I know
students who
take stimulants
orally for
nonmedical
purposes. (2)

m

m

m

m

m

I know
students who
snort
stimulants. (3)

m

m

m

m

m

I know
students on
campus who
take stimulants
for nonmedical
purposes. (4)

m

m

m

m

m

I have been
offered
stimulants by
another
student. (5)

m

m

m

m

m

I have
purchased
stimulants from
other students.
(6)

m

m

m

m

m

I have been
given
stimulants by
other students.
(7)

m

m

m

m

m

Stimulants are
as easy to get
as alcohol. (8)

m

m

m

m

m

Stimulants are
as easy to get
as marijuana.
(9)

m

m

m

m

m
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Answer If Have you ever consumed someone else's prescription stimulant medication (whether you had a
prescr... Yes Is Selected
Q267-273 I use stimulant prescription medications...

Yes (1)

No (2)

I have never used
stimulant prescription
medications (3)

To help concentrate (1)

m

m

m

To help increase
awareness/stay awake
(2)

m

m

m

To counteract effects of
other drugs (3)

m

m

m

To give a high (4)

m

m

m

To lose weight (5)

m

m

m

To control appetite (6)

m

m

m

To enhance exercise (7)

m

m

m
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Q274-293 How useful is stimulant medication for helping with the following:
Always
useful (1)

Often useful
(2)

Sometimes
useful (3)

Rarely useful
(4)

Never useful
(5)

Studying for exams
(1)

m

m

m

m

m

Writing papers (2)

m

m

m

m

m

Taking exams (3)

m

m

m

m

m

Staying awake in
class (4)

m

m

m

m

m

Giving class
presentations (5)

m

m

m

m

m

Getting to class on
time (6)

m

m

m

m

m

Earning a higher
GPA (7)

m

m

m

m

m

Pulling an "all
nighter" to study (8)

m

m

m

m

m

Pulling an "all
nighter" to write a
paper (9)

m

m

m

m

m

Enhancing eligibility
for
scholarship/financial
support (10)

m

m

m

m

m

Enhancing other
substances (11)

m

m

m

m

m

Enhancing athletic
performance (12)

m

m

m

m

m

Building muscle (13)

m

m

m

m

m

Suppressing appetite
(14)

m

m

m

m

m

Reducing fatigue
(15)

m

m

m

m

m

Avoiding getting a
worse grade (16)

m

m

m

m

m

Avoiding academic
suspension/probation
(17)

m

m

m

m

m

Avoiding losing
scholarship money
(18)

m

m

m

m

m

Increasing
concentration (19)

m

m

m

m

m

Increasing alertness
(20)

m

m

m

m

m
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Q294 How likely is it that you will engage in illicit use of prescription stimulant medication (i.e., using
someone else's prescription stimulant medication) while in college?
m
m
m
m

Very unlikely (1)
Unlikely (2)
Likely (3)
Very likely (4)

ImpSS For these questions, you will find a series of statements that people might use to describe
themselves. Read each statement and decide whether or not it describes you. If you agree with a statement
or decide that it describes you, answer TRUE. If you disagree with a statement or feel that it is not
descriptive of you, answer FALSE.
True (1)

False (2)

I often do things on impulse. (1)

m

m

I would like to take off on a trip
with no preplanned or definite
routes or timetables. (2)

m

m

I enjoy getting into new
situations where you can't predict
how things will turn out. (3)

m

m

I sometimes like to do things that
are a little frightening. (4)

m

m

I'll try anything once. (5)

m

m

I would like the kind of life
where one is on the move and
traveling a lot, with lots of
change and excitement. (6)

m

m

I sometimes do "crazy" things
just for fun. (7)

m

m

I prefer friends who are
excitingly unpredictable. (8)

m

m

I often get so carried away by
new and exciting things and ideas
that I never think of possible
complications. (9)

m

m

I like "wild" uninhibited parties.
(10)

m

m
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Q295 What is your gender?
m
m
m
m
m

Man (1)
Woman (2)
Transgender (3)
Other (4)
Prefer not to say (5)

Q296 What is your Greek affiliation?
m Current member of a fraternity or sorority (1)
m Never been a member of a fraternity or sorority (2)
m Was a member in the past, but no longer a member (3)
Q297 What is your race?
m
m
m
m
m
m
m

White or Caucasian (1)
Black or African American (2)
Asian (3)
Hispanic (4)
Pacific Islander (5)
Other (6)
Prefer not to say (7)

Q298 What is your class standing?
m
m
m
m
m
m

Freshman (first semester) (1)
Freshman (other than first semester) (2)
Sophomore (3)
Junior (4)
Senior (5)
Unclassified or graduate (6)

Q299 What is your current major?
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DATA-DRIVEN EFA SHORT-FORM
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Q146 How much of a legal risk is posed by consuming someone else's prescription
stimulant medication?
m
m
m
m

Very risky (1)
Risky (2)
Slightly risky (3)
Not risky at all (4)

Q150 How much of a health risk is posed by diverting (i.e., sharing, selling, or trading)
prescription stimulant medication?
m
m
m
m

Very risky (1)
Risky (2)
Slightly risky (3)
Not risky at all (4)

Q152-163 Please respond "Yes" or "No" to each of the following questions regarding
illicit use of prescription stimulant medication.
Yes (1)

No (2)

Have you heard of someone
at your school who has gotten
into legal trouble due to illicit
use? (153)

m

m

Have you heard of someone
at another school (not the
school you attend) who has
gotten into academic trouble
due to illicit use? (157)

m

m

Have you heard of someone
at your school who has
experienced a negative health
event due to illicit use? (159)

m

m

Have you heard of someone
at your school who has
experienced social rejection
due to illicit use? (162)

m

m
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Q168-185
Never
(1)

Rarely (2)

Sometimes
(3)

Often (4)

Very often
(5)

How often do you have
difficulty getting things in
order when you have to do
a task that requires
organization? (Q169)

m

m

m

m

m

How often do you make
careless mistakes when you
have to work on a boring or
difficult project? (Q174)

m

m

m

m

m

How often do you have
difficulty concentrating on
what people say to you,
even when they are
speaking to you directly?
(Q176)

m

m

m

m

m

How often do you have
difficulty unwinding and
relaxing when you have
time to yourself? (Q181)

m

m

m

m

m

How often do you have
difficulty waiting your turn
in situations when turn
taking is required? (Q184)

m

m

m

m

m

Q213-257 Indicate whether you would expect to experience each consequence as a result
of using a prescription stimulant medication.
Very often or always
(1)

Sometimes (2)

Not at all (3)

I feel sick to my
stomach (Q228)

m

m

m

My heart races
(Q247)

m

m

m
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Q258-266 Please answer the following questions.
Strongly
disagree
(1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly
agree (5)

I know students on
campus who take
stimulants for
nonmedical purposes.
(Q261)

m

m

m

m

m

Stimulants are as easy
to get as alcohol.
(Q265)

m

m

m

m

m
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HAND-PICKED SHORT-FORM
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Q101 Have you ever been diagnosed with ADHD (Attention-Deficit/Hyperactivity
Disorder) or ADD (Attention Deficit Disorder)?
m No (0)
m Yes (1)

Q147 How much of a health risk is posed by consuming someone else's prescription
stimulant medication?
m
m
m
m

Very risky (1)
Risky (2)
Slightly risky (3)
Not risky at all (4)

Q195 Have you ever tried marijuana?
m No (0)
m Yes (1)

Q210 Have you ever tried prescription sedatives (e.g., tranquilizers or depressants;
including Xanax, Valium, Ativan, Ambien, sleeping pills, yellow jackets) without a
prescription?
m No (0)
m Yes (1)
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Q294 How likely is it that you will engage in illicit use of prescription stimulant
medication (i.e., using someone else's prescription stimulant medication) while in
college?
m
m
m
m

Very unlikely (1)
Unlikely (2)
Likely (3)
Very likely (4)

ImpSS For these questions, you will find a series of statements that people might use to
describe themselves. Read each statement and decide whether or not it describes you. If
you agree with a statement or decide that it describes you, answer TRUE. If you disagree
with a statement or feel that it is not descriptive of you, answer FALSE.
False (0)
I often get so carried away by
new and exciting things and
ideas that I never think of
possible complications.
(ImpSS_9)

m

Q295 What is your gender?
m Woman (0)
m Man (1)

Q296 What is your Greek affiliation?
m Not current member of a fraternity or sorority (0)
m Current member of a fraternity or sorority (1)
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True (1)

m
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